<SEC-DOCUMENT>0001121404-23-000002.txt : 20230203
<SEC-HEADER>0001121404-23-000002.hdr.sgml : 20230203
<ACCEPTANCE-DATETIME>20230203114039
ACCESSION NUMBER:		0001121404-23-000002
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230203
DATE AS OF CHANGE:		20230203

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sanofi
		CENTRAL INDEX KEY:			0001121404
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				133529324
		STATE OF INCORPORATION:			I0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31368
		FILM NUMBER:		23584471

	BUSINESS ADDRESS:	
		STREET 1:		46 AVENUE DE LA GRANDE ARMEE
		CITY:			PARIS
		STATE:			I0
		ZIP:			75017
		BUSINESS PHONE:		33153774400

	MAIL ADDRESS:	
		STREET 1:		46 AVENUE DE LA GRANDE ARMEE
		CITY:			PARIS
		STATE:			I0
		ZIP:			75017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANOFI-AVENTIS
		DATE OF NAME CHANGE:	20040826

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANOFI SYNTHELABO SA
		DATE OF NAME CHANGE:	20010104
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>a6kcoverpagepressreleaseq4.htm
<DESCRIPTION>6-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i247c764a950a40f393b78bf29564f030_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM&#160;6-K</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF FOREIGN PRIVATE ISSUER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO RULE&#160;13a-16&#160;OR&#160;15d-16</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNDER THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the month of February 2023</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number&#58;&#160;001-31368</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SANOFI</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Translation of registrant&#8217;s name into English)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">46, avenue de la Grande Arm&#233;e, 75017 Paris, FRANCE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Address of principal executive offices)</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant files or will file annual reports under cover Form&#160;20-F&#160;or Form&#160;40-F.</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Form 20-F&#160;&#160;&#9746;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form&#160;40-F&#160;&#160;&#9744;</font></div><div style="margin-top:3pt;text-align:center"><font><br></font></div><div style="margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is submitting the Form&#160;6-K&#160;in paper as permitted by Regulation&#160;S-T&#160;Rule 101(b)(1)&#58;&#160;&#160;&#9744;</font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is submitting the Form&#160;6-K&#160;in paper as permitted by Regulation&#160;S-T&#160;Rule 101(b)(7)&#58;&#160;&#160;&#9744;</font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule&#160;12g3-2(b)&#160;under the Securities Exchange Act of 1934.</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yes&#160;&#160;&#9744;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No&#160;&#160;&#9746;</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><font><br></font></div><div style="margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If &#8220;Yes&#8221; marked, indicate below the file number assigned to the registrant in connection with Rule&#160;12g3-2(b)&#58;&#160;82-&#160;</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, Sanofi issued the press release attached hereto as Exhibit 99.1 which is incorporated herein by reference.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit Index</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.035%"><tr><td style="width:1.0%"></td><td style="width:20.574%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.226%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit No.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 99.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Press release dated February 3, 2023&#58; Strong sales performance and double digit EPS growth marking the achievement of the 2022 profitability milestone </font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNATURES</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.163%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.635%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; February 3, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SANOFI</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#47;s&#47; Alexandra Roger</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alexandra Roger</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Head of Securities Law and Capital Markets</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>pressreleaseq42022english.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i99a8229dc59741fa88b7606c304d7a60_1"></div><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:right"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Press Release                                                              </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><img alt="image.jpg" src="image.jpg" style="height:45px;margin-bottom:5pt;vertical-align:text-bottom;width:165px"></div><div style="padding-left:4.5pt"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:112%">Strong sales performance and double digit EPS growth marking the achievement of the 2022 profitability milestone </font></div><div style="margin-bottom:9pt;margin-top:15pt;padding-left:13.5pt;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Paris, February 3, 2023</font></div><div style="margin-bottom:3pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Q4 2022 sales growth of 2.6% at CER and business EPS</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.47pt;font-weight:700;line-height:115%;position:relative;top:-3.48pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:115%"> growth of 17.4% at CER</font></div><div style="padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.44pt">Specialty Care grew 18.1% driven by Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> (&#8364;2,402 million, +42.1%) and new product launches</font></div><div style="margin-top:3pt;padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.44pt">Vaccines sales (-16.3%) reflecting influenza and PPH sales phasing (Q3 influenza sales&#58; up 32.4%) as well as ramp up of non-consolidated Vaxelis</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> sales</font></div><div style="margin-top:3pt;padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.44pt">General Medicines core assets up 8.0% while GBU sales were lower (-3.7%) mainly due to Lantus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> and spin-off of EUROAPI  </font></div><div style="margin-top:3pt;padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.44pt">CHC sales increased 6.6% driven by double-digit growth of Digestive Wellness, Cough &#38; Cold and Allergy categories</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:15.1pt;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Full-year 2022 delivered 7.0% sales growth and 17.1% business EPS growth at CER</font></div><div style="padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.44pt">Sales grew to &#8364;42,997 million driven by Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> (&#8364;8,293 million, +43.8%), adding &#8364;3 billion of incremental sales, Vaccines up 6.3% in line with the mid-term growth objective as well as CHC strategy execution (+8.6%)</font></div><div style="margin-top:3pt;padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.44pt">Mid-term BOI margin target of 30% and cost savings objective of &#8364;2.5 billion achieved</font></div><div style="margin-top:3pt;padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.44pt">Business EPS</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> of &#8364;8.26 up 25.9% on a reported basis and 17.1% at CER </font></div><div style="margin-top:3pt;padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.44pt">IFRS EPS of &#8364;5.37 (up 8.0%)  </font></div><div style="margin-top:3pt;padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.44pt">Board held on February 2, proposes annual dividend of &#8364;3.56, an increase of 6.9%</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:15.1pt;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Progress on Corporate Social Responsibility strategy in Q4</font></div><div style="padding-left:15.1pt;text-indent:-10.8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:90%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:90%;padding-left:6.95pt">Positive phase 2&#47;3 results of acoziborole with the potential to further transform the treatment of sleeping sickness </font></div><div style="margin-top:3pt;padding-left:15.1pt;text-indent:-10.8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:90%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:90%;padding-left:6.95pt">Accelerating our ambition towards net zero emissions by 5 years, now targeting 2045 </font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:15.1pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Key R&#38;D milestones and regulatory achievements in Q4</font></div><div style="padding-left:15.1pt;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%;padding-left:6.44pt">Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:112%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%"> approved in Europe for prurigo nodularis and CHMP positive opinion for eosinophilic esophagitis</font></div><div style="margin-top:3pt;padding-left:15.1pt;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%;padding-left:6.44pt">Beyfortus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:112%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#661de8;font-family:'Georgia',serif;font-size:8pt;font-style:italic;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:112%">(</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">nirsevimab) approved in Europe for the prevention of RSV</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">disease in all infants</font></div><div style="margin-top:3pt;padding-left:15.1pt;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%;padding-left:6.44pt">VidPrevtyn</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:112%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%"> Beta approved in Europe as a booster for the prevention of COVID-19 in adults </font></div><div style="margin-top:3pt;padding-left:15.1pt;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%;padding-left:6.44pt">Enjaymo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:112%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%"> approved in Europe in adult patients with cold agglutinin disease (CAD)</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:15.1pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Full-year 2023 business EPS guidance </font></div><div style="margin-bottom:3pt;padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.44pt">Sanofi expects 2023 business EPS</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> to grow low single digit</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> at CER, barring unforeseen major adverse events. Applying average January 2023 exchange rates, the currency impact on 2023 business EPS is estimated between -3.5% to -4.5%</font></div><div style="margin-bottom:3pt;margin-top:6pt"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Sanofi Chief Executive Officer, Paul Hudson, commented&#58;</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:125%">&#8220;We closed 2022, marking the successful execution of the first chapter of our 6-year &#8216;Play to Win&#8217;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:125%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:125%">strategy. Specialty Care delivered the highest sales among our businesses. Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:125%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:125%"> and Vaccines continue to be our leading growth drivers. We are particularly proud of the progress we made in R&#38;D transformation with multiple approvals of transformative medicines and new product launches across Specialty Care. At the same time, we keep delivering strong proof points of our improved financial performance underpinned by the achievement of the 30% BOI margin. Moving to the next chapter of our strategy, we are looking forward to the planned launches of Altuviiio</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:125%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:125%"> and Beyfortus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:125%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:125%"> as well as key pivotal readouts, including the COPD indication for Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:125%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:125%">. With the view on the expected entrants of generic competition for Aubagio</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:125%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:125%"> in the coming months, we remain confident in our outstanding commercial capabilities, including the ambition to reach sales of 10 billion euros for Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:125%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:125%"> in 2023, enabling us to guide to low single-digit EPS growth for the year.&#8221;</font></div><div id="i99a8229dc59741fa88b7606c304d7a60_4"></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.558%"><tr><td style="width:1.0%"></td><td style="width:24.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:0 1pt"></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q4 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IFRS net sales reported</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;10,725m</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+7.3%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+2.6%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;42,997m</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+13.9%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+7.0%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IFRS net income reported</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;1,460m</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+29.1%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">_</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;6,720m</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+8.0%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IFRS EPS reported</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;1.16</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+28.9%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">_</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;5.37</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+8.0%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:-4.05pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Free cash flow</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="background-color:#f4f2f6;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;2,546m</font></td><td colspan="3" style="border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+0.2%</font></td><td colspan="3" style="border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">_</font></td><td colspan="3" style="background-color:#f4f2f6;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;8,483m</font></td><td colspan="3" style="border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+4.8%</font></td><td colspan="3" style="border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Business operating income</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;2,724m</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+20.7%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+15.0%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;13,040m</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+21.7%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+13.3%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:-4.05pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Business net income</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;2,141m</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+23.8%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+17.6%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;10,341m</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+25.9%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+17.0%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:-4.05pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Business EPS</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;1.71</font></td><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+23.9%</font></td><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+17.4%</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;8.26</font></td><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+25.9%</font></td><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+17.1%</font></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:115%">Changes in net sales are expressed at constant exchange rates (CER) unless otherwise indicated (definition in Appendix 9). (1) In order to facilitate an understanding of operational performance, Sanofi comments on the business net income statement. Business net income is a non-GAAP financial measure (definition in Appendix 9). The consolidated income statement for Q4 2022 is provided in Appendix 3 and a reconciliation of reported IFRS net income to business net income is set forth in Appendix 4&#59; (2) 2022 business EPS was &#8364;8.26&#59; (3) Free cash flow is a non-GAAP financial measure (definition in Appendix 9).</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  1                   </font></div></div></div><div id="i99a8229dc59741fa88b7606c304d7a60_7"></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%">2022 fourth-quarter and full-year Sanofi sales</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">----------------------------</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Unless otherwise indicated, all percentage changes in sales in this press release are stated at CER</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">---------------------</font></div><div id="i99a8229dc59741fa88b7606c304d7a60_10"></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2022, Sanofi sales were &#8364;10,725 million, up 7.3% on a reported basis. Exchange rate movements had a positive effect of 4.7 percentage points, mainly due to the U.S. dollar. At CER, company sales were up 2.6%.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, Sanofi sales reached &#8364;42,997 million, up 13.9% on a reported basis. Exchange rate movements had a positive effect of 6.9 percentage points. At CER, company sales were up 7.0%.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Global Business Units</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Fourth-quarter 2022 net sales by Global Business Unit (variation at CER&#59; &#8364; million&#59; % of total sales)</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><img alt="chart-8f98b6910d09426f888.jpg" src="chart-8f98b6910d09426f888.jpg" style="height:270px;margin-bottom:5pt;vertical-align:text-bottom;width:654px"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Fourth-quarter 2022 net sales by geographic region (variation at CER&#59; &#8364; million&#59; % of total sales)</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><img alt="chart-77caa408d3724fb9a48.jpg" src="chart-77caa408d3724fb9a48.jpg" style="height:275px;margin-bottom:5pt;vertical-align:text-bottom;width:650px"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fourth-quarter 2022 operating income</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">business operating income</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (BOI) increased 20.7% to &#8364;2,724 million. At CER, BOI increased 15.0%. The ratio of BOI to net sales increased 2.8 percentage point to 25.4% (25.3% at CER). In 2022, BOI increased 21.7% to &#8364;13,040 million. At CER, BOI increased 13.3%. The ratio of business operating income to net sales increased 1.9 percentage point to 30.3% (30.0% at CER).</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">See Appendix 9 for definitions of financial indicators.</font></div><div style="margin-top:6pt;text-align:justify"><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  2                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font><br></font></div><div id="i99a8229dc59741fa88b7606c304d7a60_13"></div><div style="margin-bottom:6pt"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%">Pharmaceuticals</font></div><div id="i99a8229dc59741fa88b7606c304d7a60_16"></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter Pharmaceutical sales increased 7.3% to &#8364;7,793 million, mainly driven by the Specialty Care portfolio (up 18.1%) with continued strong performance of Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> while sales in General Medicines decreased 3.7%. In 2022, Pharmaceuticals sales increased 6.9% to &#8364;30,688 million reflecting the strong performance of Specialty Care and General Medicines core assets.</font></div><div id="i99a8229dc59741fa88b7606c304d7a60_22"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Specialty Care</font></div><div id="i99a8229dc59741fa88b7606c304d7a60_28"></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dupixent</font></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.698%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q4 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:133%">Total Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:700;line-height:133%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,402</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+42.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,293</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+43.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the fourth quarter, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (collaboration with Regeneron) sales increased 42.1% to &#8364;2,402 million. In the U.S., Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales of &#8364;1,890 million (up 43.8%) were driven by continued strong demand in the approved indications, atopic dermatitis (AD), asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP) and the strong launches of AD in children as young as 6 months as well as eosinophilic esophagitis and prurigo nodularis. Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> total prescriptions (TRx) increased 34% (y</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ear-over-year</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) and new-to-brand prescriptions (NBRx) grew 48%. In Europe, fourth-quarter Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales grew 33.2% to &#8364;249 million reflecting continued growth in AD, asthma and CRSwNP. In the Rest of the World region, fourth-quarter sales reached &#8364;263 million, up 40.1%, driven mainly by sales in Japan and China. Full-year 2022 Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales reached &#8364;8,293 million, up 43.8%. </font></div><div id="i99a8229dc59741fa88b7606c304d7a60_34"></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Neurology and Immunology</font></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.698%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q4 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>&#160;at CER</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>&#160;at CER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Aubagio</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">493&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-4.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,031&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-4.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Lemtrada</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-15.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-8.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Kevzara</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-17.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">339&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+11.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Neurology and Immunology</font></div></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">589</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">-7.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,450</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">-2.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter and full-year 2022 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Neurology and Immunology </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">sales decreased 7.0% (to &#8364;589 million) and 2.5%, respectively, mainly due to lower Aubagio</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Aubagio</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">sales decreased 4.6% in the fourth quarter to &#8364;493 million mainly due to lower sales in </font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the Rest of the World region a</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">s a result of generic competition in Canada</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the U.S., generics of teriflunomide could enter the market on March 12, 2023, as settled with generic makers in 2017. In Europe, teriflunomide generic competition is expected in the fourth quarter of  2023.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Kevzara</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (collaboration with Regeneron) sales decreased 17.6% to &#8364;79 million due to lower sales in Europe and the Rest of the World region. This is due to a high base in the fourth quarter of 2021 which benefitted from a temporary increased global demand for IL-6 receptor blockers.</font></div><div id="i99a8229dc59741fa88b7606c304d7a60_40"></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rare Disease</font></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.698%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q4 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Myozyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">&#47; Lumizyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">216&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-17.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">958&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-8.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Fabrazyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">240&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+3.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">938&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+5.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Cerezyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">159&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-8.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">707&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+2.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Cerdelga</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">71&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+1.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">288&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+6.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Aldurazyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+1.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">267&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+6.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nexviazyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#47;Nexviadyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+306.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">196</font></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:36pt;text-align:right;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Others Rare Disease</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+126.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+11.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Rare Disease</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">850</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+1.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,445</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+5.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the fourth quarter, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Rare Disease</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales increased 1.8% to &#8364;850 million driven by the launch of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Xenpozyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">TM</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Full-year 2022 Rare Disease sales increased 5.7% reflecting growth across all three geographic regions and across all franchises.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter sales of the </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Pompe franchise</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> increased 0.4% to &#8364;281 million driven by the ramp up of Nexviazyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;&#47;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Nexviadyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in the U.S., Europe and Japan. Sales of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Nexviazyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#47;Nexviadyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> were </font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  3                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8364;65 million in the fourth quarter (of which &#8364;49 million in the U.S.). </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Myozyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#47;Lumizyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales decreased 17.7% to &#8364;216 million as a result of the conversion to Nexviazyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the eligible Pompe population (late-onset disease).</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sales of the </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Gaucher</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> franchise decreased 5.6% (to &#8364;230 million) in the fourth quarter. </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Cerezyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales were down 8.3% to &#8364;159 million, mainly reflecting lower sales in the Rest of the World region due to unfavorable shipping patterns. </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Cerdelga</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales were up 1.5% driven by new patients and Cerezyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> switch.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Fabrazyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales increased 3.6% to &#8364;240 million, reflecting growth in the U.S. and the Rest of the World region. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Xenpozyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">TM</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (olipudase alfa) was launched in the U.S., some European countries and Japan in 2022 as the first and only enzyme replacement therapy for the treatment of non-Central Nervous System (CNS) manifestations of Acid Sphingomyelinase. Fourth-quarter and full-year 2022 sales were &#8364;17 million and &#8364;21 million, respectively.</font></div><div id="i99a8229dc59741fa88b7606c304d7a60_46"></div><div style="margin-bottom:3pt;margin-top:6pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Oncology </font></div><div style="margin-bottom:1pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.698%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q4 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Jevtana</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-24.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">391&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-20.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Sarclisa</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+55.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">294&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+60.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Fasturtec</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+7.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">177&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+8.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Libtayo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-34.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Oncology</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">221</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">-11.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">952</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">-1.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Oncology</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales decreased 11.7% (to &#8364;221 million) reflecting the end of consolidation of Libatyo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales from the beginning of July. Excluding Libtayo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Oncology sales were up 3.4% with Sarclisa</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> being the main driver. Full-year 2022 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Oncology</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales decreased 1.5% and increased 3.8% when excluding Libtayo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">sales in both years. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sanofi stopped consolidating Libtayo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> non-U.S. sales from the third quarter of 2022 following the restructuring of its immuno-oncology collaboration with Regeneron Pharmaceuticals, Inc. Under the amended and restated license and collaboration agreement, Regeneron has obtained worldwide exclusive license rights to Libtayo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Prior, the companies had split equally Libtayo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8217;s worldwide operating profits and co-commercialized Libtayo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the U.S., with Sanofi solely responsible for commercialization in the rest of the world.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Sarclisa</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales were &#8364;86 million, up 55.6% primarily driven by performance in the U.S. Europe and Japan.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Jevtana</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales decreased 24.5% to &#8364;87 million due to the entry of generic competition in Europe at the end of March 2021 and lower sales in the U.S., reflecting increased competition. In the U.S., Jevtana</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> is currently covered by four Orange Book listed patents US 7,241,907, US 8,927,592, US 10,583,110 and US 10,716,777. Sanofi filed patent infringement suits under Hatch-Waxman against generic filers asserting the &#8216;110 patent, the &#8216;777 patent and the '592 patent in the US District Court for the District of Delaware. Sanofi has reached settlement agreements with most of the defendants and the suit against the only remaining defendant Sandoz is ongoing. In August 2022, the district court dismissed Sanofi&#8217;s infringement claim related to the &#8216;592 patent. A 3-day trial took place on January 11-13 2023 and Sandoz has agreed not to launch any generic cabazitaxel product until the earlier of a district court decision in favor of Sandoz or four months after the completion of the post-trial briefing.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font><br></font></div><div id="i99a8229dc59741fa88b7606c304d7a60_52"></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rare Blood Disorders </font></div><div style="margin-bottom:1pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:19.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.873%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q4 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Eloctate</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">138&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-9.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">580&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-5.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Alprolix</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">141&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+14.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">504&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+10.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Cablivi</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+52.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">211&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+20.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Enjaymo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">TM</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:36pt;text-align:right;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:36pt;text-align:right;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Rare Blood Disorders</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">352</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+11.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,317</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+5.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth quarter and full-year 2022 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Rare Blood Disorders</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> franchise sales increased 11.3% (to &#8364;352 million) and 5.6% respectively, driven by Alprolix</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:1.41pt;vertical-align:baseline">, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cablivi</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and the launch of</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Enjaymo&#8482;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:1.41pt;vertical-align:baseline">,</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">more than</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">offsetting lower Eloctate</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  4                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Eloctate</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales were &#8364;138 million in the fourth quarter, down 9.2% reflecting lower sales in the U.S. due to competitive pressure. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Alprolix</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales were up 14.2% to &#8364;141 million driven by the Rest of the World region which includes sales to Sobi. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Cablivi</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales increased by 52.6% to &#8364;62 million in the fourth quarter supported by the performance in the U.S. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter and full-year sales of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Enjaymo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8482;, the first approved treatment for patients with cold agglutinin disease were &#8364;11 million and &#8364;22 million, respectively (launched in the U.S. and Japan in 2022 and approved in Europe in November 2022). </font></div><div id="i99a8229dc59741fa88b7606c304d7a60_58"></div><div style="margin-top:12pt"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:120%">General Medicines</font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter General Medicines sales decreased 3.7% to &#8364;3,379 million. The deconsolidation of EUROAPI</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> third party sales had a negative impact of -3.6 percentage point (ppt) and divestments of non-core assets -0.7 ppt. Fourth-quarter Industrial sales were &#8364;177 million, down </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">22.7%</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and reflected deconsolidation of EUROAPI third party sales from May 10.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Full-year 2022 General Medicines sales decreased 4.2% to &#8364;14,231 million. The deconsolidation of EUROAPI third party sales had a negative impact of -2.4ppt and divestments of non-core assets -0.8ppt in 2022. In 2022, Industrial sales were &#8364;620 million, down 26.2% and reflected deconsolidation of EUROAPI third party sales. In 2022, core assets</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales accounted for 47% of General Medicines sales compared with 43% in 2021 (excluding Industrial sales).</font></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Core assets</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.558%"><tr><td style="width:1.0%"></td><td style="width:31.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.732%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q4 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Lovenox</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;*</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">289&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-13.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,310&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-13.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Toujeo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">272&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+13.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,117&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+9.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Plavix</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">245&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+11.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">983&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+2.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Praluent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">96&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+70.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">376&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+65.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thymoglobulin</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">118&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+26.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">446&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+16.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Multaq</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-6.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">383&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+4.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mozobil</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+3.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">261&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+4.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Soliqua</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-5.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">215&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+1.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rezurock</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+180.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">207&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:36pt;text-align:right;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Others</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">287&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+3.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,091&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-0.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total core assets</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,598</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+8.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,389</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+5.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">*</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Excluding Auto generics</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the fourth quarter and full-year 2022, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">core assets</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales increased 8.0% (to &#8364;1,598 million) and 5.2%, respectively, mainly driven by growth of Praluent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Toujeo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Thymoglobulin</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and as well as the strong performance of Rezurock</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, partially offset by lower sales of Lovenox</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Lovenox</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">sales decreased 13.1% to &#8364;289 million, reflecting lower COVID-19 related demand compared to 2021, leading to a decrease</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Low Weight Molecular Heparins market. At the same time biosimilar competition increased. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Toujeo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> sales increased 13.9% to &#8364;272 million, due to strong growth in the Rest of the World region primarily driven by China reflecting increasing demand and a favorable basis for comparison. In Q4 2021, sales in China were impacted by </font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">price and inventory adjustment in anticipation of the Volume Based Procurement (VBP) for insulins. Sales in the U.S. were down 7.5% reflecting lower average price in the fourth quarter which more than offset volume growth. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Plavix</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">sales were up 11.7% in the fourth quarter at &#8364;245 million, reflecting consistent volume growth in China (sales up 21.6% to &#8364;108 million) which largely offset lower sales in Europe and also Japan where the product was impacted by a mandatory price cut at the beginning of April.</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Praluent</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> fourth-quarter sales were &#8364;96 million, up 70.9%,</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">driven by performance in Europe and an accelerated ramp-up in China due to the inclusion in the National Reimbursement Drug List (NRDL) effective January 2022.</font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">EUROAPI third party sales were deconsolidated from May 10</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Sanofi has prioritized core assets in its General Medicines portfolio with differentiated and&#47;or established profiles that have significant opportunity for growth in key markets. </font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  5                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Multaq</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> fourth-quarter sales decreased 6.1% to &#8364;104 million, reflecting a negative price effect in the U.S. despite higher volume.</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Soliqua</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales were &#8364;55 million, down 5.6% due to lower sales in the U.S. which more than offset growth in the Rest of the World region. Soliqua</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> was approved in January in China and Sanofi will work with Chinese authorities to get access to patients through inclusion into the NRDL. </font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sales of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Rezurock</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> were &#8364;63 million in the fourth quarter. Since launch more than 1400 patients have been treated with Rezurock</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (representing more than 30% of current addressable patient population) with strong persistency rates. </font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Non-core assets </font></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.558%"><tr><td style="width:1.0%"></td><td style="width:31.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.732%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q4 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Lantus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;*</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">429&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-27.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,259&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-14.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Aprovel</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#47;Avapro</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-9.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">478&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+7.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other non-core assets</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,071&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-1.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,485&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-7.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total non-core assets</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,604</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">-10.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7,222</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">-9.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the fourth quarter, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">non-core assets sales </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">decreased 10.8% to &#8364;1,604 million reflecting divestments (-1.9 ppt), and lower sales of Lantus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the U.S. In 2022, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">non-core assets sales </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">decreased 9.0% (and 7.4% excluding divestments), reflecting VBP impact in China on Lantus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Eloxatin</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and Taxotere</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales as well as lower Lantus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales in the U.S.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Lantus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales were &#8364;429 million, down 27.6% in the fourth quarter. In the U.S., sales decreased 56.7%, impacted by prior formulary losses as well as by erosion of the basal insulin market. In Rest of the World region, sales were down 7.7% reflecting the insulin VBP in China starting in May this year. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In China, Sanofi participated in the VBP tender for basal insulin analogues in November 2021 and was among the bidding winners in Group A with Toujeo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and Lantus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. In China, fourth-quarter</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Toujeo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:1.41pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Lantus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales were &#8364;51 million (up 18.6%), mainly reflecting higher Toujeo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales which benefited from growing demand and a favorable base of comparison due to </font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">price and inventory adjustment in the fourth quarter of 2021 in anticipation of the VBP</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. In 2022, Toujeo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and Lantus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales were &#8364;447 million (down 10.7%), mainly reflecting lower Lantus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales which benefitted from higher volumes at sig</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">nificantly lower prices.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Aprovel</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:700;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">&#47;Avapro</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> sales were down 9.8% to &#8364;104 millio</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">n mainly due to lower sales in the Rest of the World </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">region.</font></div><div id="i99a8229dc59741fa88b7606c304d7a60_64"></div><div style="margin-top:6pt;text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Pharmaceuticals business operating income</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the fourth quarter, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">business operating income</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (BOI) of Pharmaceuticals increased 19.1% to &#8364;2,490 million (up 15.1% at CER). The ratio of BOI to net sales increased by 1.8 percentage point to 32.0% (32.4% at CER), reflecting an improvement of the gross margin ratio, moderate growth of SG&#38;A expenses despite continued increase in R&#38;D expenses. In 2022, business operating income of Pharmaceuticals increased 17.4% to &#8364;11,043 million (up 10.5% at CER). The ratio of BOI to net sales increased by 1.1 percentage point to 36.0% (36.0% at CER). </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  6                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font><br></font></div><div id="i99a8229dc59741fa88b7606c304d7a60_70"></div><div style="margin-bottom:3pt;margin-top:6pt"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%">Vaccines</font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:700;line-height:115%"> </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.698%"><tr><td style="width:1.0%"></td><td style="width:33.353%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.286%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.286%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.286%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.289%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q4 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:174%">Influenza vaccines</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">(incl. Fluzone</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%"> HD&#47; Efluelda</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">, Fluzone</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">, Flublok</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">, Vaxigrip</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">802&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-32.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,977&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+2.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:174%">Polio&#47;Pertussis&#47;Hib vaccines </font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">(incl. Hexaxim</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%"> &#47; Hexyon</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">, Pentacel</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">, Pentaxim</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:700;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">and Imovax</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">443&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-16.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,285&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+2.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:174%">Meningitis vaccines </font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">(incl. Menactra</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">MenQuadfi</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">110&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+14.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">703&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-3.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:174%">Booster vaccines </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">(incl. Adacel</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:174%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">148&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+12.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">587&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+11.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Travel and endemic vaccines</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">121&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+28.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">510&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+57.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other vaccines</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">92&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+309.1%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">167&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+86.9%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Vaccines</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,716</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">-16.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7,229</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+6.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Vaccines</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales decreased 16.3% (to &#8364;1,716 million) mainly reflecting accelerated supply phasing of influenza vaccines between the third and the fourth quarter 2022. In 2022, Vaccines sales were up 6.3%, reflecting  progressive recovery of Travel and Booster vaccines.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Influenza vaccines</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales decreased 32.0% to &#8364;802 million in the fourth quarter and accounted for 30% of northern hemisphere sales in the second half of 2022 compared to 45% in the fourth quarter of 2021. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">New manufacturing capacity in the U.S. allowing for a new record year for influenza vaccines sales. This was again driven by continuous conversion to differentiated premium priced vaccines such as Fluzone</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> HD in the U.S. and Efluelda</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in Europe that have demonstrated improved efficacy against a standard dose vaccine in randomized controlled trials. Full-year 2022 influenza sales reached &#8364;2,977 million.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the fourth quarter, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Polio&#47;Pertussis&#47;Hib</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (PPH) vaccines sales decreased -16.9% to &#8364;443 million reflecting lower sales in the Rest of the World region due to unfavorable purchasing pattern. In addition, Pentaxim</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales in China decreased due to the COVID disruption. In the U.S. Vaxelis</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:1.41pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">continues to capture market share progressively replacing pentavalent vaccines in the primary series of infant immunization. As a reminder, Vaxelis</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in-market sales are not consolidated and the profits are shared equally between Sanofi and Merck &#38; co. Full-year 2022 PPH sales reached &#8364;2,285 million.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Meningitis</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales increased 14.3% to &#8364;110 million, reflecting significant growth in the Rest of the World region. In the U.S., Meningitis sales benefited from favorable purchasing pattern. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Booster</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> vaccines sales increased 12.1% in the fourth quarter to &#8364;148 million, driven by the Rest of the World region.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Travel and endemic vaccines</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales increased 28.6% to &#8364;121 million, reflecting growth across all geographies in a post pandemic environment.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sales of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Other Vaccines</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> were &#8364;92 million (up +309.1%) in the fourth quarter and included also sales of the recently approved monovalent recombinant-protein COVID-19 booster vaccine VidPrevtyn</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Beta.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font><br></font></div><div id="i99a8229dc59741fa88b7606c304d7a60_76"></div><div style="text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Vaccines business operating income</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the fourth quarter, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">business operating income</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (BOI) decreased 8.3% (down 13.6% at CER) to &#8364;599 million compared to the same period of last year, reflecting earlier time to market of flu vaccines sales, higher R&#38;D expenses related to the mRNA center of excellence which were partially offset by the capital gain generated by the sale of the Japanese encephalitis vaccine, a non-core vaccine. BOI to net sales ratio was 34.9% (34.3% at CER) versus 33.2% in the fourth quarter of 2021. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In 2022, BOI of Vaccines increased 21.4% (up 9.8% at CER) to &#8364;3,168 million reflecting strong sales growth, gross margin improvement, moderate SG&#38;A evolution despite higher R&#38;D costs. The ratio of BOI to net sales was 43.8% (42.6% at CER) versus 41.3% in 2021.</font></div><div style="margin-top:6pt;text-align:justify"><font><br></font></div><div id="i99a8229dc59741fa88b7606c304d7a60_82"></div><div><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  7                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><font><br></font></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%">Consumer Healthcare</font></div><div style="margin-bottom:1pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:22.363%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q4 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">Change </font></div><div style="text-align:right"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">at CER</font></div></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">Change </font></div><div style="text-align:right"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">at CER</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Allergy</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">156&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+15.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">734&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+10.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cough &#38; Cold </font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">132&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+11.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">478&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+46.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pain Care</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">303&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+8.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,213&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+7.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Digestive Wellness</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">306&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+12.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,318&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+12.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Physical and Mental Wellness</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">124&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-8.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">562&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+0.7%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Personal Care</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">157&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+8.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">586&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+2.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-Core &#47; Others</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-29.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">189&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-27.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Consumer Healthcare</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,216</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+6.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,080</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+8.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the fourth quarter, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Consumer Healthcare</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (CHC) sales increased 6.6% to &#8364;1,216 million driven by growth in all regions. This global performance includes a positive price effect of 4.7 percentage points (ppt). The divestments of non-core products had a negative impact of 0.9 ppt in the fourth quarter mainly impacting the Non-core&#47;others category. (The CHC organic sales growth was 7.5% in the fourth quarter excluding divestments impact). In 2022, CHC sales increased 8.6% supported by double-digit growth in Europe and the Rest of the World region. In 2022, the divestments of non-core products had a negative impact of 1.0 ppt. (The CHC organic sales growth was 9.6% in 2022 excluding divestments impact). </font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> U.S.</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, fourth-quarter CHC sales increased 3.9% to &#8364;326 million driven by Digestive Wellness and Personal Care categories.</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Europe</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, fourth-quarter CHC sales increased 8.7% to &#8364;371 million mainly reflecting double-digit growth of Cough &#38; Cold season and </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Digestive Wellness categories</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. </font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Rest of World</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, fourth-quarter CHC sales increased 6.6% to &#8364;519 million, supported by double-digit growth of Pain Care and Allergy categories.</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font><br></font></div><div id="i99a8229dc59741fa88b7606c304d7a60_88"></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">CHC business operating income</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the fourth quarter, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">business operating income</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (BOI) of CHC increased 27.9% (up 25.5% at CER) to &#8364;381 million, driven by solid sales performance, moderate SG&#38;A growth as well as higher capital gains related to divestments of non-strategic assets. The ratio of BOI to net sales increased 4.5 percentage points to 31.3% (31.6% at CER) versus the fourth quarter of 2021. In 2022</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">BOI of CHC increased 21.2% (up 15.8% at CER) to &#8364;1,810 million mainly driven by sales growth and higher capital gains related to divestments of non-strategic assets. The ratio of BOI to net sales increased 2.2 percentage points to 35.6% (35.6% at CER).</font></div><div id="i99a8229dc59741fa88b7606c304d7a60_94"></div><div style="margin-top:6pt"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%">Company sales by geographic region</font></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.838%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Sanofi sales (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q4 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,671</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">+8.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">18,275</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">+12.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,636</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">-5.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,999</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">+2.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of the World</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,418</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">+2.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">14,723</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">+4.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">of which China</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">578&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+2.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">3,123&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+6.2%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">of which Japan</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">406&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+10.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">1,613&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+3.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">of which Brazil</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">204&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+4.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">927&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-2.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:133%">of which Russia</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">172&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-0.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">674&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+0.7%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Sanofi sales</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,725</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+2.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">42,997</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+7.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">U.S., </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">fourth-quarter sales increased 8.7% (to &#8364;4,671 million), supported by the strong performance of Specialty Care driven by Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Europe,</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> fourth-quarter sales decreased 5.6% (to &#8364;2,636 million) reflecting lower flu vaccines sales and deconsolidation of Libtayo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales, partially offset by Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and CHC performance. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Rest of World region, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">fourth-quarter sales increased 2.4% (to &#8364;3,418 million), reflecting the performance of Specialty Care driven by Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, growth of General Medicines core assets and CHC which largely offset lower Vaccines sales. Sales in </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">China</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> increased 2.3% to &#8364;578 million, driven by Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Praluent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Plavix</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and Toujeo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> which more than offset the</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:1.41pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">VBP impact on Lantus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and lower Vaccines sales. In</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> Japan,</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> fourth-quarter sales increased 10.9% to &#8364;406 million mainly driven by the </font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  8                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">growth of Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">,</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Sarclisa</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and CHC. In </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Brazil</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, fourth-quarter sales were up 4.9% driven by General Medicines core-assets. Full-year 2022 sales in Brazil were down 2.0% reflecting lower Vaccines and Lovenox</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> sales. In </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Russia</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, fourth-quarter sales decreased 0.7% to 172 million. In March 2022, Sanofi has stopped any new spending not related to the supply of its essential and life-changing medicines and vaccines in Russia. This includes all advertising and promotional spending.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  9                   </font></div></div></div><div id="i99a8229dc59741fa88b7606c304d7a60_100"></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%">R&#38;D update at the end of the fourth quarter 2022</font></div><div><font><br></font></div><div><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Regulatory update</font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%"> </font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">The European Commission (EC) approved </font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Beyfortus</font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (nirsevimab) for the prevention of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">respiratory syncytial virus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (RSV) lower respiratory tract disease in newborns and infants during their first RSV season. RSV is a common and highly contagious seasonal virus, infecting nearly all children by the age of two. Beyfortus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> is the first and only single-dose RSV protective option for the broad infant population, including those born healthy, at term or preterm, or with specific health conditions. Beyfortus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">was also granted approval in the United Kingdom.</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">The U.S. Food and Drug Administration (FDA) accepted</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the Biologics License Application (BLA) for </font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Beyfortus</font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> for the prevention of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">respiratory syncytial virus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (RSV) lower respiratory tract disease in newborns and infants entering or during their first RSV season and for children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season. </font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">The EC expanded the marketing authorization for </font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Dupixent</font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (dupilumab) in the European Union to treat adults with moderate-to-severe </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">prurigo nodularis</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (PN) who are candidates for systemic therapy. With this approval, Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> is the first and only targeted medicine specifically indicated to treat PN in Europe and the U.S.</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">The European Medicines Agency&#8217;s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for </font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Dupixent</font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, recommending the approval in Europe, to treat adults and adolescents with </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">eosinophilic esophagitis</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (EoE). </font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;padding-left:19pt">VidPrevtyn</font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> Beta</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> was approved by the EC, as a booster for the </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">prevention of COVID-19</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in adults who have previously received an mRNA or adenoviral COVID-19 vaccine. Designed to provide broad protection against multiple variants, the protein-based COVID-19 booster vaccine is based on the Beta variant antigen and includes GSK&#8217;s pandemic adjuvant.</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:19pt">The EC granted marketing authorization for </font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Enjaymo</font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (sutimlimab) for the treatment of adult patients with </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">cold agglutinin disease</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (CAD), a rare, serious, and chronic autoimmune hemolytic anemia.</font></div><div style="padding-left:36pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:17.05pt">Regeneron announced that the FDA approved </font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Libtayo</font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (cemiplimab-rwlc) in combination with platinum-based chemotherapy for the first-line treatment of adult patients with advanced </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">non-small cell lung cancer</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (NSCLC) with no EGFR, ALK or ROS1 aberrations.This approval triggered Sanofi receiving a $100 million regulatory milestone payment</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Portfolio update</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Phase 3&#58;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The </font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Dupixent</font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Phase 3 results in adults and adolescents with </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">eosinophilic esophagitis</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (EoE) were published in the New England Journal of Medicine. Dupixent is the first and only targeted medicine indicated in the U.S. to treat EoE patients aged 12 and older, weighing at least 40 kg. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:12.55pt">The </font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:110%">tolebrutinib</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> Phase 3 trial in </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%">nrSPMS</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> (non-relapsing secondary progressive multiple sclerosis, HERCULES) was fully recruited in December 2022. Non-relapsing SPMS is an area of highest unmet need in MS as no approved treatments are currently available. Sanofi continues to recruit in PERSEUS, the trial for </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:110%">PPMS</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> (primary progressive MS), outside of the U.S.</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The URSA study, a randomized, double blind, placebo-controlled trial evaluating the efficacy and safety of </font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">tolebrutinib</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in patients with moderate-to-severe </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">myasthenia gravis</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (MG) was discontinued after careful evaluation of the emerging competitive treatment landscape in MG. </font></div><div><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Phase 2&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">The study evaluating </font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">eclitasertib</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (RIPK1 inhibitor) in patients with </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">ulcerative colitis</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (UC) enrolled its first participants.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Sanofi decided to terminate its collaboration program with Revolution Medicines for the development of </font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">SAR442720 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(SHP2 inhibitor) for the treatment of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">solid tumors</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, following a pipeline review and reprioritization of projects.</font></div><div><font><br></font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:103%">Phase 1&#58;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The development program for </font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">SAR444419</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (anti-TNFa&#47;IL-6 Nanobody</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> VHH) in </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">inflammatory indication</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> was initiated.</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The study evaluating </font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">SAR444559</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, an anti-CD38 mAb of next generation in </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">inflammatory indication</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> enrolled its first participants.</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The study of the anti PD1&#47;IL-15 fusion protein, </font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">SAR445877</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (formerly known as KD050, entering our pipeline through Kadmon acquisition) in patients with </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">solid tumors</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> enrolled its first participants.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  10                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The study evaluating the safety and tolerability of intravenous </font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">SAR446159</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (also known as ABL301), an anti-alpha-synuclein&#47;IGF1R mAb in </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Parkinson&#8217;s Disease</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, was initiated in collaboration with ABL Bio.</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The randomized, double-blind study evaluating the safety, tolerability, and activity of </font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">SAR439459 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(anti-TGFb mAb), for the treatment of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Osteogenesis Imperfecta</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, was initiated. </font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Three Phase 1&#47;2 studies with different LNP formulations evaluating the safety and immunogenicity of </font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Quadrivalent Influenza mRNA vaccine</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in adults, enrolled their first participants.</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The Phase 1&#47;2 study evaluating the safety and immunogenicity of the </font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">RSV mRNA vaccine in older adults</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, formulated with 2 different LNPs, enrolled its first participants.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Acquisitions and major collaborations</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#7a00e6;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Sanofi and Innate Pharma announced an </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">expansion of their collaboration</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, with Sanofi licensing a natural killer (NK) cell engager program targeting B7H3 from Innate&#8217;s ANKET</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">TM</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (Antibody-based NK Cell Engager Therapeutics) platform. Sanofi will also have the option to add up to two additional ANKET</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">TM</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> targets. Upon candidate selection, Sanofi will be responsible for all development, manufacturing and commercialization. </font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">An update of the R&#38;D pipeline at as of Dec 31, 2022, is available on our website</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#58; </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">https&#58;&#47;&#47;www.sanofi.com&#47;en&#47;science-and-innovation&#47;research-and-development </font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  11                   </font></div></div></div><div id="i99a8229dc59741fa88b7606c304d7a60_106"></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%">Corporate Social Responsibility update at the end of the fourth quarter 2022</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:102%">Access to medicines</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Positive Phase 2&#47;3 results of acoziborole with the potential to further transform the treatment of sleeping sickness</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sanofi has collaborated with the World Health Organization (WHO) since 2001, with the objective to contribute to eliminate sleeping sickness, or Human African Trypanosomiasis (HAT), by 2030. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sleeping sickness is a neglected tropical disease, which affects mostly poor populations living in remote rural areas of sub-Saharan Africa. If left untreated, the parasitic disease is usually fatal. Since the start of Sanofi&#8217;s collaboration with the WHO, the number of cases of sleeping sickness has fallen by 97%, from 26,950 in 2001 to 805 in 2021, dropping below 1,000 for the fourth consecutive year. Through Sanofi's partnership with the World Health Organization (WHO), the company supports disease management, including screening of populations, disease awareness campaign, capacity building, as well as drug donation. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In September 2020, Sanofi and the Drugs for Neglected Diseases initiative (DNDi) signed an agreement to develop and roll out acoziborole, a single dose treatment administered at the point of diagnosis making it a potential game-changer to support the sustainable elimination of the disease once approved. This new chemical entity has been tested in Phase 2&#47;3 clinical studies in Democratic Republic of Congo and Guinea. The results, which were published in the Lancet Infectious Diseases medical journal in November 2022, showed that the 18-month treatment success rate for acoziborole was 95% in late-stage g-HAT patients. The study shows that acoziborole has a favorable safety profile, with no significant drug-related safety signals being reported. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Upon approval, acoziborole could replace fexinidazole, also developed by Sanofi and DNDi and first approved in 2018. Fexinidazole is a ten-day once-a-day treatment that is effective in both the first and the second stages of the disease in adults and children aged six years and older. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:102%">Environment</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Accelerating our ambition towards net zero emissions by 5 years, now targeting 2045</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sanofi is accelerating its efforts to address climate change and now build the road to net zero emissions across all operations (scope 1 &#38; 2) and the entire value chain (scope 3) by 2045. This is an acceleration of 5 years compared to Sanofi&#8217;s previous commitment towards net zero emissions by 2050.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This new commitment will be building on years of work to reduce the environmental footprint of its products and activities. The progress of Sanofi&#8217;s environmental strategy is disclosed in appendix 10&#58; CSR dashboards. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:102%">ESG ratings</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sanofi has been recognized again on the 2022 CDP&#8217;s Climate Change A List for its commitment and transparency in the fight against climate change. In addition, Sanofi has also achieved the leadership score (A-) for its actions to protect water resources.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sanofi has also been awarded the 2022 Terra Carta Seal. The Seal is being awarded to companies from around the world who are driving innovation and leadership in their industry and tackling climate change. All recipients must have credible transition roadmaps underpinned by globally recognised, scientific metrics for achieving net zero by 2050 or earlier and have ambitions aligned with those of the Terra Carta, a recovery plan for Nature, People and Planet. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, in recognition of Sanofi&#8217; continued CSR strategy implementation, a few of Sanofi&#8217;s ESG rankings have been positively updated&#58;</font></div><div><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  12                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><img alt="esgratingsq4v2.jpg" src="esgratingsq4v2.jpg" style="height:330px;margin-bottom:5pt;vertical-align:text-bottom;width:716px"></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  13                   </font></div></div></div><div id="i99a8229dc59741fa88b7606c304d7a60_109"></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%">Fourth-quarter and full-year 2022 financial results</font></div><div style="margin-top:3pt"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Business Net Income</font><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:7.8pt;font-weight:700;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">4</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the fourth quarter of 2022, Sanofi generated</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> net sales</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of &#8364;10,725 million, an increase of 7.3% (up 2.6% at CER). Full-year 2022 net sales were &#8364;42,997 million up 13.9% (up 7.0% at CER).</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">other revenues</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> increased 73.6% (up 58.2% at CER) to &#8364;731 million, including increased VaxServe sales of non-Sanofi products of &#8364;413 million (up 27.4% at CER). In 2022, other revenues increased 69.2% (up 51.9% at CER) to &#8364;2,392 million, including VaxServe sales of non-Sanofi products of &#8364;1,567 million (up 28.5% at CER).</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Gross Profit</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> increased 11.2% (up 5.4% at CER) to &#8364;7,722 million. The gross margin ratio increased 2.5 percentage point to 72.0% versus the same period of 2021, reflecting positive currency effect, improvement of the Pharmaceuticals gross margin ratio (which increased from 75.4% to 77.1%) driven by favorable product mix and efficiency gains and Vaccines gross margin ratio (58.9% from 56.0%), benefitting from a favorable comparison basis. CHC gross margin ratio increased 0.2 percentage point to 62.7%. In 2022, the gross margin ratio increased 2.4 percentage points to 73.7% (73.1% at CER) driven by Pharmaceuticals and Vaccines.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Research and Development </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(R&#38;D)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">expenses were up 15.0% (up 10,1% at CER) to &#8364;1,823 million in the fourth quarter, reflecting increased expenses in pharmaceuticals priority assets and early-stage projects as well as in Vaccines. In 2022, R&#38;D expenses increased 17.8% to &#8364;6,706 million (up 12.3% at CER). </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">selling general and administrative expenses</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (SG&#38;A) increased 5.0% to &#8364;2,895 million. At CER, SG&#38;A expenses were stable, reflecting efficiency measures which more than offset increased commercial investments in Specialty Care growth drivers. In the fourth quarter, the ratio of SG&#38;A to sales decreased 0.6 percentage point to 27.0% compared to the prior year. In 2022, SG&#38;A expenses increased 9.8% to &#8364;10,492 million (up 3.3% at CER) and the ratio of SG&#38;A to sales was 0.9 percentage point lower at 24.4% compared to 2021.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter and full-year 2022 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">operating expenses</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> were &#8364;4,718 million, (up 8.6% and 3.7% at CER) and &#8364;17,198 million (up 12.8% and 6.6% at CER).</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">other current operating income net of expenses</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> was &#8364;-276 million versus &#8364;-356 million in the fourth quarter of 2021. Other current operating income net of expenses included an expense of &#8364;659 million (versus an expense of &#8364;444 million in the fourth quarter of 2021) corresponding to the share of profit to Regeneron of the monoclonal antibodies Alliance, additional share of profit paid by Regeneron towards development costs (which increased from 10% to 20% from April 1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.47pt;font-weight:400;line-height:115%;position:relative;top:-3.48pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9.96pt;font-weight:400;line-height:115%">)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.47pt;font-weight:400;line-height:115%;position:relative;top:-3.48pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and the reimbursement of commercialization-related expenses incurred by Regeneron. In the fourth quarter, this line also included &#8364;227 million of net capital gains related to portfolio streamlining compared to &#8364;61 million in the same period of 2021. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2022, other current operating income net of expenses was &#8364;-1,514 million versus &#8364;-946 million in 2021 and included &#8364;615 million of net capital gains related to portfolio streamlining compared to &#8364;318 million in 2021.  In 2022 expense associated with the monoclonal antibodies Alliance with Regeneron was &#8364;2,367 million, which compared with an expense of &#8364;1,429 million in 2021 (see appendix 7 for further details).</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The fourth-quarter and full-year </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">share of profit from associates </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">was &#8364;6 million and &#8364;88 million versus &#8364;18 million and &#8364;39 million in the same periods of 2021, respectively, and included the share of U.S. profit related to Vaxelis</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">business operating income</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (BOI) increased 20.7% to &#8364;2,724 million. At CER, BOI increased 15.0%. The ratio of BOI to net sales increased 2.8 percentage points to 25.4%. In 2022, BOI was &#8364;13,040 million, up 21.7% (up 13.3% at CER). In 2022, the ratio of business operating income to net sales increased 1.9 percentage point to 30.3% (30.0% at CER).</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Net financial expenses</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> were &#8364;-28 million and &#8364;-234 million in the fourth quarter and full-year 2022, respectively, versus &#8364;-83 million and &#8364;-328 million in the same periods of 2021. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">effective tax rate</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> was 20,6% versus 20.5% in the same periods of 2021. Full-year 2022 effective tax rate was 19.3% versus 20.9% in 2021. Sanofi expects its effective tax rate to be around 19% in 2023.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Fourth-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">business net income</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> increased 23.8% to &#8364;2,141 million and increased 17.6% at CER. The ratio of business net income to net sales increased 2.7 percentage points to 20.0% versus the fourth quarter of 2021. In 2022, business net income increased 25.9% to &#8364;10,341 million and increased 17.0% </font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">ee Appendix 3 for 2022 fourth-quarter consolidated income statement&#59; see Appendix 9 for definitions of financial indicators, and Appendix 4 for reconciliation of IFRS net income reported to business net income</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">. </font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  14                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">at CER. The ratio of business net income to net sales increased 2.4 percentage points to 24.1% versus 2021.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the fourth quarter of 2022,</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> business earnings per share</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(EPS) was &#8364;1.71, up 23.9% on a reported basis (up 17,4% at CER). The average number of shares outstanding was 1,254.0 million versus 1,254.9 million in the fourth quarter of 2021. In 2022, business earnings per share</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.47pt;font-weight:400;line-height:115%;position:relative;top:-3.48pt;vertical-align:baseline">8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> was &#8364;8.26, up 25.9% on a reported basis and up 17.1% at CER. The average number of shares outstanding was 1,251.9 million versus 1,252.5 million in 2021.</font></div><div id="i99a8229dc59741fa88b7606c304d7a60_112"></div><div style="margin-top:6pt;text-align:justify"><font><br></font></div><div><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Reconciliation of IFRS net income reported to business net income (see Appendix 4) </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2022, the IFRS net income was &#8364;6,720 million</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:115%">. </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The main items excluded from the business net income were&#58;</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.55pt">An amortization charge of &#8364;2,053 million related to fair value remeasurement on intangible assets of acquired companies (primarily Genzyme&#58; &#8364;535 million, Bioverativ&#58; &#8364;377 million, Boehringer Ingelheim CHC business&#58; &#8364;188 million, Ablynx&#58; &#8364;168 million and Kadmon &#8364;159 million) and to acquired intangible assets (licenses&#47;products&#58; &#8364;334 million). These items have no cash impact on the Company.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">An impairment of intangible assets of &#8364;1,700 million o</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">f which &#8364;1,586 million are </font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">related to SAR444245 recorded in the third quarter.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.55pt">An upfront payment of $900 million (&#8364;856 million) and a regulatory milestone payment of $100 million (&#8364;96 million) received by Sanofi from Regeneron following the restructuring of the Immuno-Oncology agreement and collaboration. These items are included in Consolidated income statements line </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Other Operating Income </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(see Appendix 7).</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.55pt">Restructuring costs and similar items of &#8364;1,336 million related to streamlining initiatives.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.55pt">Other gains and losses, and litigation charge of &#8364;370 million, mainly including costs related to major litigations (including the estimated future defense costs relating to the Zantac</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> litigation).</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.55pt">A &#8364;962 million tax effect arising from the items listed above, mainly comprising &#8364;771 million of deferred taxes generated by amortization and impairments of intangible assets and</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8364;231 </font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">million associated with restructuring costs and similar items (see Appendix 4). </font></div><div style="margin-top:3pt;text-align:justify"><font><br></font></div><div><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Capital Allocation</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2022, free cash flow before restructuring, acquisitions and disposals decreased by 10.8% to &#8364;8,902 million, after net changes in working capital </font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(&#8364;-477 milli</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">on) and capital expenditures (&#8364;-1,594 million). After acquisitions</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (&#8364;-824 million</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, proceeds from disposals</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (&#8364;1,531 million) and payments related to restructuring and similar items (-&#8364;1,126 million), </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">free cash flow</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> increased 4.8%</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">to &#8364;8,483 million. After the acquisition of Amunix (-&#8364;875 million), the dividend paid by Sanofi (-&#8364;4,168 million), net debt decreased from &#8364;9,983 million at December 31, 2021 to &#8364;6,437 million at December 31, 2022 (amount </font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">net of &#8364;12</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">,736 </font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">milli</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">on cash and cash equivalents).</font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Not exceeding &#8364;500 million per transaction (inclusive of all payments related to the transaction).</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">non-GAAP financial measure (definition in Appendix 9).</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  15                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="text-align:justify;text-indent:216pt"><font><br></font></div><div id="i99a8229dc59741fa88b7606c304d7a60_121"></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Forward-Looking Statements</font></div><div style="text-align:justify"><font style="color:#404040;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:112%">This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words &#8220;expects&#8221;, &#8220;anticipates&#8221;, &#8220;believes&#8221;, &#8220;intends&#8221;, &#8220;estimates&#8221;, &#8220;plans&#8221; and similar expressions. Although Sanofi&#8217;s management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labelling and other matters that could affect the availability or commercial potential of such product candidates, the fact that product candidates if approved may not be commercially successful, the future approval and commercial success of therapeutic alternatives, Sanofi&#8217;s ability to benefit from external growth opportunities, to complete related transactions and&#47;or obtain regulatory clearances, risks associated with intellectual property and any related pending or future litigation and the ultimate outcome of such litigation, trends in exchange rates and prevailing interest rates, volatile economic and market conditions, cost containment initiatives and subsequent changes thereto, and the impact that COVID-19 will have on us, our customers, suppliers, vendors, and other business partners, and the financial condition of any one of them, as well as on our employees and on the global economy as a whole. The risks and uncertainties also include the uncertainties discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under &#8220;Risk Factors&#8221; and &#8220;Cautionary Statement Regarding Forward-Looking Statements&#8221; in Sanofi&#8217;s annual report on Form 20-F for the year ended December 31, 2021. Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font><br></font></div><div id="i99a8229dc59741fa88b7606c304d7a60_124"></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%">Appendices</font></div><div><font><br></font></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:12.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.353%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Appendix&#160;1&#58;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth-quarter and full-year 2022 sales by GBU, franchise, geographic region and product</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i99a8229dc59741fa88b7606c304d7a60_133" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Appendix 2&#58;</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth-quarter<a href="#i99a8229dc59741fa88b7606c304d7a60_133" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none"> </a>and full-year <a href="#i99a8229dc59741fa88b7606c304d7a60_133" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">2022 business net income statement</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i99a8229dc59741fa88b7606c304d7a60_139" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Appendix 3&#58;</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth-quarter and full-year <a href="#i99a8229dc59741fa88b7606c304d7a60_139" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">2022 consolidated income statement</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i99a8229dc59741fa88b7606c304d7a60_142" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Appendix 4&#58;</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i99a8229dc59741fa88b7606c304d7a60_142" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Reconciliation of IFRS net income reported to business net income</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:174%"><a href="#i99a8229dc59741fa88b7606c304d7a60_145" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:174%;text-decoration:none">Appendix 5&#58;</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:174%"><a href="#i99a8229dc59741fa88b7606c304d7a60_145" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:174%;text-decoration:none">Change in net debt</a></font></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Appendix 6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Simplified consolidated balance sheet</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Appendix 7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current operating income net of expenses &#8211; Regeneron Alliances</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Appendix 8&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency sensitivity</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i99a8229dc59741fa88b7606c304d7a60_160" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Appendix </a>9&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i99a8229dc59741fa88b7606c304d7a60_160" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Definitions of non-GAAP financial indicators</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Appendix 10&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CSR Dashboards</font></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt"><font><br></font></div><div style="text-align:justify"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Media Relations</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Sandrine Guendoul </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 33 6 25 09 14 25 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">sandrine.guendoul&#64;sanofi.com</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Nicolas Obrist </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 33 6 77 21 27 55 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">nicolas.obrist&#64;sanofi.com</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Victor Rouault </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 33 6 70 93 71 40 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">victor.rouault&#64;sanofi.com</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Chrystel Baude </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 33 6 70 98 70 59 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">chrystel.baude&#64;sanofi.com</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Sally Bain </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 1 617 834 6026 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">sally.bain&#64;sanofi.com</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Evan Berland</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%"> &#124; +1 215 432 0234 &#124; </font><font style="color:#5400b8;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">evan.berland&#64;sanofi.com</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Kate Conway </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 1 508 364 4931 &#124; </font><font style="color:#7900e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%;text-decoration:underline">kate.conway&#64;sanofi.com</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Investor Relations</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Eva Schaefer-Jansen </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 33 7 86 80 56 39 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">eva.schaefer-jansen&#64;sanofi.com </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Arnaud Del&#233;pine </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 33 6 73 69 36 93 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">arnaud.delepine&#64;sanofi.com </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Corentine Driancourt </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 33 6 40 56 92 21 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">corentine.driancourt&#64;sanofi.com  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Felix Lauscher </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 1 908 612 7239 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">felix.lauscher&#64;sanofi.com </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Nathalie Pham </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 33 7 85 93 30 17 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">nathalie.pham&#64;sanofi.com</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Tarik Elgoutni</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 1 617 528 8427 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Tarik.Elgoutni&#64;sanofi.com </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  16                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div id="i99a8229dc59741fa88b7606c304d7a60_130"></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Appendix 1&#58; 2022 fourth-quarter and full-year net sales by GBU, franchise, geographic region and product</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:21.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.358%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.358%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.358%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.289%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q4 2022<br>(&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Sales</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% reported</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Europe</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rest of the world</font></td><td colspan="3" style="background-color:#23004c;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dupixent</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,402</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+42.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+55.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,890</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+43.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">249</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+33.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">263</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+40.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Aubagio</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">493</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.1&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">357</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">123</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-1.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">13</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-58.8&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Lemtrada</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">17</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-15.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-10.5&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-16.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-16.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">7</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-14.3&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Kevzara</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">79</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-17.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-13.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">44</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">25</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-32.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-44.4&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Neurology &#38; Immunology</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">589</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-7.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+0.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">406</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+0.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">153</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-8.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">30</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-49.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cerezyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">159</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-8.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-12.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">50</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-2.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">56</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-8.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">53</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-12.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cerdelga</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">71</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">40</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">28</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+25.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Myozyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">216</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-17.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-15.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">73</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-26.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">99</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">44</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-27.1&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Nexviazyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">65</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+306.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+333.3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">49</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+214.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">8</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+800.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">8</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Fabrazyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">240</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.6&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">123</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">58</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-1.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">59</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.7&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Aldurazyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">65</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">16</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-6.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">21</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">28</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.4&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rare Disease</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">850</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+1.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+3.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">355</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+4.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">282</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+3.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">213</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-3.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Jevtana</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">87</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-24.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-20.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">59</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-25.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">7</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-58.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">21</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.5&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Fasturtec</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">47</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+14.6&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">31</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Libtayo</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-100.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-100.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sarclisa</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">86</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+55.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+59.3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">35</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+52.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">27</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+30.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">24</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+100.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Oncology</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">221</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-11.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-7.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">125</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-3.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">47</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-42.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">49</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+20.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Alprolix</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">141</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+14.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+24.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">101</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">40</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+50.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Eloctate</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">138</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-9.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-2.1&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">97</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-14.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">41</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.1&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cablivi</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">62</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+52.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+63.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">36</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+73.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">22</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+21.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rare Blood Disorder</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">352</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+11.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+20.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">241</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+4.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+21.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">89</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+30.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Care</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,414</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+18.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+26.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,017</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+24.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">753</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+3.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">644</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+11.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Lovenox</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">289</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-13.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-13.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-40.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">154</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-8.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">132</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-17.4&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Toujeo</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">272</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+18.3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">69</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-7.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">106</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">97</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+55.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Plavix</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">245</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.4&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">25</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-7.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">218</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+14.5&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Multaq</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">104</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-6.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.1&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">94</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-6.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-40.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">7</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+50.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Thymoglobulin</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">118</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+26.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+35.6&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">76</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+25.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">9</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">33</font></td><td colspan="2" style="border-left:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+37.5&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Mozobil</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">69</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+9.5&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">41</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+20.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-16.7&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Praluent</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">96</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+70.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+74.5&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">65</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+46.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">31</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+180.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Soliqua&#47;iGlarLixi</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">55</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-5.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">30</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-15.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">7</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-12.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+21.4&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Rezurock</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">63</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+180.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+215.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">63</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+180.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Others core assets</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">287</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">62</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-21.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">94</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">131</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+23.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Core Assets</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,598</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+8.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+11.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">440</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+4.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">482</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+2.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">676</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+14.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Lantus</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">429</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-27.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-26.4&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">115</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-56.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">104</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-9.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">210</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-7.7&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Aprovel</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">104</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-9.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-7.1&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-33.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">20</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">82</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-10.2&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Others non-core assets</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,071</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-1.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-1.6&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">112</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-15.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">269</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-12.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">690</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.4&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-Core Assets</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,604</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-10.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-10.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">229</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-43.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">393</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-11.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">982</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+0.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Industrial Sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">177</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-22.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-19.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-75.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">171</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-18.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-70.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">General Medicines</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,379</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-3.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-1.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">671</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-18.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,046</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-6.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,662</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+5.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pharmaceuticals</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,793</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+7.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+12.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,688</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+13.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,799</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-2.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,306</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+7.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Polio &#47; Pertussis &#47; Hib</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">443</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-16.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-18.4&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">80</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-31.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">80</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-1.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">283</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-16.3&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Booster Vaccines</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">148</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+19.4&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">73</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">39</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-11.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">36</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+84.2&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Meningitis </font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">110</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+14.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+20.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">54</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-24.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">51</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+79.3&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Influenza Vaccines</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">802</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-32.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-26.6&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">404</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-9.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">248</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-46.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">150</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-39.6&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Travel and Endemic Vaccines</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">121</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+28.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+33.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">28</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+62.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">24</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+47.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">69</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.8&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Vaccines</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,716</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-16.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-12.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">657</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-11.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">466</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-22.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">593</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-15.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Allergy</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">156</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+15.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+22.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">91</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">7</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">58</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+41.5&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cough and Cold</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">132</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">74</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+15.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">58</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.9&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Pain Care</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">303</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">56</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">141</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">106</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+24.7&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Digestive Wellness</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">306</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">45</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+20.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">107</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+18.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">154</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Physical Wellness</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">69</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-15.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-12.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">7</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-22.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">62</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-14.3&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Mental Wellness</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">55</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">14</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">22</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">19</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.9&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Personal Care</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">157</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+18.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">126</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">31</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.4&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Non-Core &#47; Others</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">38</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-29.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-30.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(6)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-700.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">13</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+9.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">31</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-23.3&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consumer Healthcare</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,216</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+6.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+9.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">326</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+3.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">371</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+8.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">519</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+6.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Company</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,725</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">+2.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">+7.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4,671</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">+8.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,636</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">-5.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,418</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">+2.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td></tr></table><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%"> </font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  17                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font><br></font></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:21.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.358%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.358%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.358%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.289%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022<br>(&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Sales</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% reported</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Europe</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rest of the world</font></td><td colspan="3" style="background-color:#23004c;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dupixent</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,293</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+43.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+58.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,346</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+41.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">940</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+44.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,007</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+56.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Aubagio</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,031</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,420</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">511</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">100</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-26.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Lemtrada</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">80</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-8.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-2.4&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">31</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-20.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">22</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-8.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">27</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.7&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Kevzara</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">339</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+18.1&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">186</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+23.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">106</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">47</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Neurology &#38; Immunology</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,450</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-2.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+5.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,637</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-1.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">639</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+0.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">174</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-15.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cerezyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">707</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.5&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">194</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-0.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">239</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-2.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">274</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+9.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cerdelga</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">288</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.4&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">160</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">111</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">17</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.9&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Myozyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">958</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-8.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.5&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">318</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-24.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">408</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-0.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">232</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1.8&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Nexviazyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">196</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+952.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1052.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">158</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+833.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">17</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+750.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">21</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Fabrazyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">938</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.1&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">471</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">228</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">239</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.1&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Aldurazyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">267</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+9.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">61</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">86</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">120</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.3&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rare Disease</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,445</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+5.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+10.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,367</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+6.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,104</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+3.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">974</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+7.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Jevtana</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">391</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-20.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-14.1&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">275</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">33</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-70.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">83</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.4&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Fasturtec</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">177</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+16.4&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">113</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">48</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">16</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Libtayo</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">88</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-34.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-31.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">70</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-34.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-33.3&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sarclisa</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">294</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+60.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+67.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">127</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+68.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">88</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+35.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">79</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+82.2&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Oncology</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">952</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-1.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+4.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">515</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+12.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">239</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-27.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">198</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+15.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Alprolix</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">504</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+21.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">406</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">98</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+17.1&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Eloctate</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">580</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-5.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">450</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-6.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">130</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cablivi</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">211</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+20.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+28.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">110</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+21.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">94</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+16.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">7</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+200.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rare Blood Disorder</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,317</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+5.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+15.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">983</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+3.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">94</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+16.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">240</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+8.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Care</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">16,457</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+19.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+29.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,848</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+22.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,016</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+8.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,593</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+20.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Lovenox</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,310</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-13.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-11.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">17</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-48.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">658</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-5.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">635</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-19.9&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Toujeo</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,117</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+9.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+15.3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">283</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">421</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">413</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+23.7&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Plavix</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">983</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">9</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-11.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">101</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-12.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">873</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.7&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Multaq</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">383</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+16.4&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">347</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">16</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-27.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">20</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+26.7&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Thymoglobulin</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">446</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+16.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+27.4&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">269</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+15.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">34</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">143</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+24.8&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Mozobil</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">261</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">154</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">67</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">40</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-11.4&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Praluent</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">376</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+65.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+72.5&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">55</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+860.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">229</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+41.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">92</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+61.5&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Soliqua&#47;iGlarLixi</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">215</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">119</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-7.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">29</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">67</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+23.5&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Rezurock</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">207</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+815.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+935.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">206</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+815.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Others core assets</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,091</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-0.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">194</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-30.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">361</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">536</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+14.4&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Core Assets</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,389</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+5.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+10.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,653</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+11.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,917</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+2.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,819</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+3.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Lantus</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,259</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-14.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-9.4&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">757</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-22.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">426</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-10.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,076</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-10.4&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Aprovel</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">478</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+14.1&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">7</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-40.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">82</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-5.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">389</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.7&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Others non-core assets</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4,485</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-7.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-5.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">412</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-10.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,129</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-11.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,944</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-5.6&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-Core Assets</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,222</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-9.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-5.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,176</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-18.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,637</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-10.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,409</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-5.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Industrial Sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">620</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-26.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-23.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-63.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">587</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-21.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">16</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-63.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">General Medicines</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">14,231</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-4.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+0.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,846</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-4.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,141</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-6.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,244</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-2.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pharmaceuticals</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">30,688</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+6.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+13.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">13,694</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+15.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,157</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-0.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9,837</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+2.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Polio &#47; Pertussis &#47; Hib</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,285</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">456</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-13.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">325</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,504</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.2&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Booster Vaccines</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">587</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+20.3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">330</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">154</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">103</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+55.6&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Meningitis</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">703</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">531</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">15</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1400.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">157</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-8.2&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Influenza Vaccines</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,977</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,737</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">681</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-6.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">559</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-0.4&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Travel and Endemic Vaccines</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">510</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+57.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+66.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">153</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+57.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">94</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+123.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">263</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+42.7&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Vaccines</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,229</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+6.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+14.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,291</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+3.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,341</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+9.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,597</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+8.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Allergy</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">734</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+19.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">439</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">55</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">240</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+19.8&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cough and  Cold</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">478</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+46.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+49.4&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">263</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+69.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">215</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+24.4&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Pain Care</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,213</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">212</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">555</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">446</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.4&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Digestive Wellness</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,318</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+16.5&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">144</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">432</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">742</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+14.9&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Physical Wellness</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">324</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+0.3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">23</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-20.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">301</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-2.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Mental Wellness</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">238</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">51</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-2.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">107</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">80</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.8&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Personal Care</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">586</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">453</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-75.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">132</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Non-Core &#47; Others</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">189</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-27.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-27.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(9)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-200.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">65</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-27.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">133</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-18.8&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consumer Healthcare</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,080</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+8.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+13.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,290</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+0.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,501</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+13.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,289</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+10.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Company</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">42,997</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">+7.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">+13.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">18,275</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">+12.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,999</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">+2.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14,723</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">+4.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  18                   </font></div></div></div><div id="i99a8229dc59741fa88b7606c304d7a60_133"></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Appendix 2&#58; Business net income statement</font></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:14.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.184%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.184%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.486%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.486%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.486%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.486%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.184%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.358%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fourth quarter 2022</font></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pharmaceuticals</font></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Vaccines</font></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consumer Healthcare</font></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Other</font><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font></div></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Group</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8364; million</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Q4 2022</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Q4 2021</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Q4 2022</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Q4 2021</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Q4 2022</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Q4 2021</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Q4 2022</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Q4 2021</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Q4 2022</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Q4 2021</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">7,793</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">6,919</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">12.6%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,716</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,964</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">-12.6%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,216</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,111</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">9.5%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#8212;%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">10,725</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">9,994</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">7.3%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other revenues</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">232</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">112</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">107.1%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">479</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">295</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">62.4%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">16</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">14</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">14.3%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#8212;%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">731</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">421</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">73.6%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of Sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2,015)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,817)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">10.9%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,184)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,159)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">2.2%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(469)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(431)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">8.8%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(66)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(64)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">3.1%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(3,734)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(3,471)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">7.6%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(25.9)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(26.3)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(69.0)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(59.0)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(38.6)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(38.8)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(34.8)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(34.7)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Profit</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">6,010</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">5,214</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">15.3%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,011</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,100</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">-8.1%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">763</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">694</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">9.9%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(62)</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(64)</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">-3.1%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">7,722</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">6,944</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">11.2%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">77.1%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">75.4%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">58.9%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">56.0%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">62.7%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">62.5%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">72.0%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">69.5%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,328)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,185)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">12.1%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(264)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(210)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">25.7%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(56)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(49)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">14.3%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(175)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(141)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">24.1%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,823)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,585)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">15.0%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(17.0)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(17.1)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(15.4)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(10.7)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(4.6)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(4.4)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(17.0)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(15.9)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,677)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,565)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">7.2%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(272)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(248)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">9.7%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(367)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(361)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">1.7%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(579)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(584)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">-0.9%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2,895)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2,758)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">5.0%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(21.5)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(22.6)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(15.9)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(12.6)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(30.2)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(32.5)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(27.0)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(27.6)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current operating income&#47;expenses</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(506)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(376)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">121</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">39</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">11</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">70</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(276)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(356)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit&#47;loss of associates* and joint ventures</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">9</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">6</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">6</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non controlling interests</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(9)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(6)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(10)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(7)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business operating income</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2,490</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2,091</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">19.1%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">599</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">653</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">-8.3%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">381</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">298</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">27.9%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(746)</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(786)</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">-5.1%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2,724</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2,256</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">20.7%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">32.0%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">30.2%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">34.9%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">33.2%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">31.3%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">26.8%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">25.4%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">22.6%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial income and expenses</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(28)</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(83)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income tax expenses</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(555)</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(443)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Tax rate**</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">20,6%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">20,5%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business net income</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="9" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2,141</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,730</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">23.8%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">20.0%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">17.3%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business earnings &#47; share(in euros)***</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1.71</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1.38</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">23.9%</font></td></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">* Net of tax.&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">** Determined on the basis of Business income before tax, associates, and non-controlling interests.</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">*** Based on an average number of shares outstanding of 1,254.0 million in the fourth quarter of 2022 and 1,254.9 million in the fourth quarter of 2021.</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:9pt;text-indent:-9.01pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:2pt">Other includes the cost of global support functions (Finance, Human Resources, Information Solution &#38; Technologies, Sanofi Business Services, etc&#8230;).</font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  19                   </font></div></div></div><div id="i99a8229dc59741fa88b7606c304d7a60_136"></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Appendix 2&#58; Business net income statement</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:4.49pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.419%"><tr><td style="width:1.0%"></td><td style="width:14.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Full Year 2022</font></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pharmaceuticals</font></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Vaccines</font></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consumer Healthcare</font></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Other</font><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font></div></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Group</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8364; million</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">FY 2022</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FY 2021</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">FY 2022</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FY 2021</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">FY 2022</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FY 2021</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">FY 2022</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FY 2021</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">FY 2022</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FY 2021</font></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">30,688</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">26,970</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">13.8%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">7,229</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">6,323</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">14.3%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">5,080</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">4,468</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">13.7%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#8212;%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">42,997</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">37,761</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">13.9%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other revenues</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">657</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">264</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">148.9%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,666</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,095</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">52.1%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">62</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">55</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">12.7%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">7</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#8212;%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,392</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,414</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">69.2%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of Sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(7,511)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(6,965)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">7.8%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(4,101)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(3,430)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">19.6%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,827)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,606)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">13.8%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(253)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(250)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">1.2%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(13,692)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(12,251)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">11.8%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(24.5)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(25.8)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(56.7)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(54.2)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(36.0)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(35.9)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(31.8)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(32.4)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Profit</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">23,834</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">20,269</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">17.6%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">4,794</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">3,988</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">20.2%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">3,315</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2,917</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">13.6%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(246)</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(250)</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">-1.6%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">31,697</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">26,924</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">17.7%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">77.7%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">75.2%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">66.3%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">63.1%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">65.3%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">65.3%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">73.7%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">71.3%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(5,067)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(4,330)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">17.0%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(936)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(712)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">31.5%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(187)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(153)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">22.2%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(516)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(497)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">3.8%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(6,706)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(5,692)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">17.8%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(16.5)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(16.1)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(12.9)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(11.3)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(3.7)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(3.4)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(15.6)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(15.1)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(5,923)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(5,326)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">11.2%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(870)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(805)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">8.1%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,478)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,388)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">6.5%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2,221)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2,036)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">9.1%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(10,492)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(9,555)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">9.8%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(19.3)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(19.7)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(12.0)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(12.7)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(29.1)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(31.1)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(24.4)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(25.3)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current operating income&#47;expenses</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,800)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,172)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">132</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">128</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">152</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">111</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(13)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,514)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(946)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit&#47;loss of associates* and joint ventures </font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">28</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">17</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">48</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">11</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">11</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">88</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">39</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non controlling interests</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(29)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(49)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(4)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(5)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(33)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(56)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business operating income</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> </font></div></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">11,043</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">9,409</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">17.4%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">3,168</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2,609</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">21.4%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,810</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,493</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">21.2%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(2,981)</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(2,797)</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">6.6%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">13,040</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">10,714</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">21.7%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">36.0%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">34.9%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">43.8%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">41.3%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">35.6%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">33.4%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">30.3%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">28.4%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial income and expenses</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(234)</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(328)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income tax expenses</font></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2,465)</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2,173)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Tax rate**</font></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">19.3%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">20.9%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business net income</font></td><td colspan="9" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">10,341</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">8,213</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">25.9%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">As % of net sales</font></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">24.1%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">21.7%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business earnings &#47; share(in euros)***</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">8.26</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">6.56</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">25.9%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt;text-indent:4.49pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:1pt;text-indent:4.49pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">    </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">    * Net of tax.&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">** Determined on the basis of Business income before tax, associates, and non-controlling interests.</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">*** Based on an average number of shares outstanding of 1,251.9 million in the full year of 2022 and 1,252.5 million in the full year of 2021.</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:9pt;text-indent:-9.01pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:2pt">Other includes the cost of global support functions (Finance, Human Resources, Information Solution &#38; Technologies, Sanofi Business Services, etc&#8230;).</font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  20                   </font></div></div></div><div id="i99a8229dc59741fa88b7606c304d7a60_139"></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Appendix 3&#58; Consolidated income statements</font></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:54.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.074%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8364; million</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q4 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q4 2021</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FY 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FY 2021</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net sales</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,725</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,994</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">42,997</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">37,761</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other revenues</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">731&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">421&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,392&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,414&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,734)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,475)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,695)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,255)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross profit</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7,722</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,940</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">31,694</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">26,920</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expenses</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,823)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,585)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,706)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,692)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling and general expenses</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,895)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,758)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,492)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,555)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating income</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">778&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,403&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">859&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating expenses</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(958)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(548)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,965)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,805)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(457)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(420)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,053)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,580)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:10pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Impairment of intangible assets</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,700)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(192)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value remeasurement of contingent consideration</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring costs and similar items</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(170)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(326)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,336)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(820)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:10pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other gains and losses, and litigation</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(233)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(370)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating income</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,949</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,474</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,502</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,126</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financial expenses</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(148)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(93)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(440)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(368)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financial income</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income before tax and associates and joint ventures</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,921</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,391</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,268</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7,798</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(407)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(268)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,503)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,558)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of profit&#47;(loss) of associates and joint ventures</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,517</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,141</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,833</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,279</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income attributable to equity holders of Sanofi</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,460</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,131</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,720</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,223</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average number of shares outstanding (million)</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,254.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,254.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,251.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,252.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;border-top:2pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">IFRS Earnings per share (in euros)</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;border-top:2pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.16</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;border-top:2pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;border-top:2pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.90</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;border-top:2pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;border-top:2pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5.37</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;border-top:2pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;border-top:2pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.97</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;border-top:2pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  21                   </font></div></div></div><div id="i99a8229dc59741fa88b7606c304d7a60_142"></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Appendix 4&#58; Reconciliation of Net income attributable to equity holders of Sanofi to Business net income</font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:52.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.492%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.492%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.933%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8364; million</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q4 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Q4 2021</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FY 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FY 2021</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income attributable to equity holders of Sanofi</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,460</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,131</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,720</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,223</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Amortization of intangible assets </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">457&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">420&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,053&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,580&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Impairment of intangible assets </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,700&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value remeasurement of contingent consideration </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expenses arising from the impact of acquisitions on inventories</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income resulting from license-out </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(96)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(952)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring costs and similar items</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">326&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,336&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">820&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Other gains and losses, and litigation </font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">233&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">370&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax effect of the items listed above&#58;</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(148)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(174)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(962)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(614)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Amortization and impairment of intangible assets</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(143)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(95)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(771)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(415)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Fair value remeasurement of contingent consideration</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(4)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(9)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(2)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Restructuring costs and similar items</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(30)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(79)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(231)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(200)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Other tax effects</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">23&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">49&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other items</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business net income</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,141</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,730</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,341</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,213</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">IFRS earnings per share </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(5) </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in euros)</font></div></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.16</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">0.90</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5.37</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.97</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.21pt">Of which related to amortization expense generated by the remeasurement of intangible assets as part of business combinations&#58; &#8364;430 million in the fourth quarter of 2022 and &#8364;397 million in the fourth quarter of 2021.</font></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.21pt">In Q3 2022, impairment of &#8364;1,586 million related to SAR&#8217;245 Non-alpha IL2.</font></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.21pt">In 2022, including non-controlling interest impact of &#8364;(80) million resulting from fair value adjustment of a contingent consideration in a subsidiary</font></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.21pt">Upfront payment of $900 million (Q3 2022) and, regulatory milestone of 100m$ (Q4 2022) in connection with Libtayo license-out reported in the Consolidated income statements line Other Operating Income.  </font></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(5)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:5.66pt">Q4&#58; Based on an average number of shares outstanding of 1,254.0 million in the fourth quarter of 2022 and 1,254.9 million in the fourth quarter of 2021.</font></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;FY&#58; Based on an average number of shares outstanding of 1,251.9 million in the full year of 2022 and 1,252.5 million in the full year of 2021.</font></div><div style="margin-top:3pt;text-indent:36pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  22                   </font></div></div></div><div id="i99a8229dc59741fa88b7606c304d7a60_145"></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Appendix 5&#58; Change in net debt</font></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.766%"><tr><td style="width:1.0%"></td><td style="width:70.039%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.330%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.331%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8364; million</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FY 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;FY 2021</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business net income</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,341</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,213</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation &#38; amortization &#38; impairment of property, plant and equipment and software</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,587&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,469&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other items</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(955)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating cash flow</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,973</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,902</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in Working Capital</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(477)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,475&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions of property, plant and equipment and software</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,594)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,400)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Free cash flow before restructuring, acquisitions and disposals</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,902</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,977</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquisitions of intangibles assets, investments and other long-term financial assets </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(824)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,488)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring costs and similar items paid</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,126)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,060)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Proceeds from disposals of property, plant and equipment, intangible assets and other non-current assets net of taxes</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#160;(1)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,531&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">667&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Free cash flow</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,483</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,096</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquisitions of investments in consolidated undertakings including</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">assumed debt </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,192)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,298)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Proceeds from disposals of assets net of taxes </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of Sanofi shares</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition of treasury shares</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(497)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(382)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends paid to shareholders of Sanofi</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,168)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,008)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other items</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (3)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">631&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in net debt</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,546</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1,193)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;border-top:2pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Beginning of period</font></td><td colspan="2" style="background-color:#f4f2f6;border-top:2pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,983</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-top:2pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-top:2pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,790</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-top:2pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Closing of net debt</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,437</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,983</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.21pt">Free cash flow includes investments and divestments not exceeding a cap of &#8364;500 million per transaction (inclusive of all payments related to the transaction).</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.21pt">Includes transactions that are above a cap of &#8364;500 million per transaction (inclusive of all payments related to the transaction).</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.21pt">In 2022, includes upfront payment of $900 million and regulatory milestone of $100 million received as part of Libtayo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> license-out.</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  23                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div id="i99a8229dc59741fa88b7606c304d7a60_148"></div><div><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Appendix 6&#58; Simplified consolidated balance sheet</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.022%"><tr><td style="width:1.0%"></td><td style="width:22.831%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.831%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.225%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">Assets (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">December 31, 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">December 31, 2021</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">Liabilities &#38; equity  (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">December 31, 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">December 31, 2021</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Equity attributable to equity holders of Sanofi</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">73,144</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">68,681</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Equity attributable to non-controlling interests</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">368</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">350</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">Total equity</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">73,512</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">69,031</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Long-term debt</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">14,857</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">17,123</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Property, plant and equipment - Owned Assets</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">9,869</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">10,028</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Non-current lease liabilities</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">1,904</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">1,839</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Right-of-use assets</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">1,815</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">1,948</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Non-current liabilities related to business combinations and to non-controlling interests</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">674</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">577</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Intangible assets (including goodwill)</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">69,395</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">69,463</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Non-current provisions and other non-current liabilities</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">6,341</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">6,721</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Non-current income tax assets</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">242</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">175</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Non-current income tax liabilities</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">1,979</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">2,039</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Non-current financial assets &#38; investments in associates and deferred tax assets</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">9,153</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">7,975</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Deferred tax liabilities</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">1,344</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">1,617</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">Non-current assets</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">90,474</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">89,589</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">Non-current liabilities</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">27,099</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">29,916</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Accounts payable &#38; Other current liabilities</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">18,834</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">17,397</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Current liabilities related to business combinations and to non-controlling interests</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">105</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">137</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Inventories, accounts receivable and other current assets</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">20,916</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">19,854</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Current income tax liabilities</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">574</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">309</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Current income tax assets</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">374</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">612</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Current lease liabilities</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">277</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">269</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Cash and cash equivalents</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">12,736</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">10,098</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Short-term debt and current portion of long-term debt</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">4,174</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">3,183</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">Current assets</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">34,026</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">30,564</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">Current liabilities</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">23,964</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">21,295</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Assets held for sale or exchange</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">85</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">89</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Liabilities related to assets held for sale or exchange</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">10</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:83%">0</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">Total assets</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;text-indent:13.5pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">124,585</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;text-indent:13.5pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">120,242</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">Total equity and liabilities</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;text-indent:13.5pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">124,585</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;text-indent:13.5pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">120,242</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  24                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div id="i99a8229dc59741fa88b7606c304d7a60_154"></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Appendix 7&#58; Other current operating income net of expenses &#8211; Regeneron Alliances</font></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.318%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:83%">&#8364; million</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:83%">2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:83%">2021</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Monoclonal </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Antibodies Alliance</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:10pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Income &#38; Expense related to profit&#47;loss sharing</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:83%">(2,325)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(1,253)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:10pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Additional share of profit paid by Regeneron related to development costs</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:83%">434</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:10pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:115%">127</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:10pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Regeneron commercial operating expenses reimbursement</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:83%">(476)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:10pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(303)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:10pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total&#58; Monoclonal Antibody Alliance</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:83%">(2,367)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:10pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(1,429)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Immuno-Oncology Alliance</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:10pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Total Immuno-Oncology Alliance</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:83%">16</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:115%">68</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Other Regeneron</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:10pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Total others related to Regeneron (mainly Libtayo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:115%">and Zaltrap</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:115%">) </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:83%">168</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:115%">(12)</font></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:83%">Total Regeneron Alliances</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:83%">(2,183)</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:83%">(1,373)</font></td></tr></table></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:112%">(1) This line excludes an upfront payment of $900 million and a regulatory milestone payment of $100 million received by Sanofi from Regeneron in connection with the Amended IO Discovery Agreement signed in June 2022. These items are included in the Consolidated income statements line Other Operating Income.</font></div><div><font><br></font></div><div id="i99a8229dc59741fa88b7606c304d7a60_157"></div><div style="margin-bottom:6pt"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Appendix 8&#58; Currency sensitivity</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023 business EPS currency sensitivity</font></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.698%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Currency</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Variation</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business EPS Sensitivity</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Dollar</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">+0.05 USD&#47;EUR</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;-EUR 0.17</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Japanese Yen</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">+5 JPY&#47;EUR</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-EUR 0.02</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chinese Yuan</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">+0.2 CNY&#47;EUR</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;-EUR0.03</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brazilian Real</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">+0.4 BRL&#47;EUR</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;-EUR0.02</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Russian Ruble</font></td><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">+10 RUB&#47;EUR</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;-EUR 0.02</font></td></tr></table></div><div style="margin-top:4pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:87%">Currency exposure on Q4 2022 sales</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:87%"> </font></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Currency</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q4 2022</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">US $</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Euro &#8364;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chinese Yuan</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Japanese Yen</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brazilian Real</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mexican pesos</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Russian ruble</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canadian $</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australian $</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">British Pound</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Others</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-top:4pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:80%">Currency average rates </font></div><div style="margin-bottom:4pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:0 1pt"></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q4 2021</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q4 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Change</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8364;&#47;$</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.144&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.021&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">-10.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8364;&#47;Yen</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130.065&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144.203&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">+10.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8364;&#47;Yuan</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.315&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.264&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">-0.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8364;&#47;Real</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.387&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.372&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">-15.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8364;&#47;Ruble</font></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83.108&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.072&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">-22.9&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:4pt;margin-top:6pt"><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  25                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:4pt;margin-top:6pt"><font><br></font></div><div id="i99a8229dc59741fa88b7606c304d7a60_160"></div><div style="margin-bottom:3pt;margin-top:6pt"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Appendix 9&#58; Definitions of non-GAAP financial indicators</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Company sales at constant exchange rates (CER)</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When we refer to changes in our net sales &#8220;at constant exchange rates&#8221; (CER), this means that we exclude the effect of changes in exchange rates.</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We eliminate the effect of exchange rates by recalculating net sales for the relevant period at the exchange rates used for the previous period.</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Reconciliation of net sales to Company sales at constant exchange rates for the fourth quarter and the full-year 2022</font></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.698%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8364; million</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Q4  2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net sales</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,725</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">42,997</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rates</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">475&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,585&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Company sales at constant exchange rates</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,250</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">40,412</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:7pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Business net income</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sanofi publishes a key non-GAAP indicator. Business net income is defined as net income attributable to equity holders of Sanofi excluding&#58;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">amortization of intangible assets,</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">impairment of intangible assets, </font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">fair value remeasurement of contingent consideration related to business combinations or to disposals,</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">expenses arising from the impact of acquisitions on inventories</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">other impacts associated with acquisitions (including impacts of acquisitions on associates and joint ventures),</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">restructuring costs and similar items</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">other gains and losses (including gains and losses on disposals of non-current assets</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">),</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">costs or provisions associated with litigation</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">tax effects related to the items listed above as well as effects of major tax disputes,</font></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">net income attributable to non-controlling interests</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">related to the items listed above.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(1) Reported in the line items </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:120%">Restructuring costs</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:120%">and similar items</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:120%">Gains and losses on disposals, and litigation</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">, which are defined in Notes B.19. and B.20. to our consolidated financial statements.</font></div><div style="margin-bottom:6pt;margin-top:12pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Free cash flow </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Free cash flow is a non-GAAP financial indicator which is reviewed by our management, and which we believe provides useful information to measure the net cash generated from the Company&#8217;s operations that is available for strategic investments</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (net of divestments</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), for debt repayment, and for capital return to shareholders. Free Cash Flow is determined from the Business Net Income adjusted for depreciation, amortization and impairment, share of profit&#47;loss in associates and joint ventures net of dividends received, gains &#38; losses on disposals, net change in provisions including pensions and other post-employment benefits, deferred taxes, share-based expense and other non-cash items. It comprises net changes in working capital, capital expenditures and other asset acquisitions</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> net of disposal proceeds</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and payments related to restructuring and similar items. Free cash flow is not defined by IFRS and it is not a substitute measure for the IFRS aggregate net cash flows in operating activities.</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Amount of the transaction above a cap of &#8364;500 million per transaction (inclusive of all payments related to the transaction).</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Not exceeding a cap of &#8364;500 million per transaction (inclusive of all payments related to the transaction).</font></div><div><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  26                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><font><br></font></div><div id="i99a8229dc59741fa88b7606c304d7a60_163"></div><div style="margin-bottom:6pt;margin-top:12pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Reconciliation from net cash provided by&#47;(used in) operating activities to free cash flow</font></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.419%"><tr><td style="width:1.0%"></td><td style="width:74.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.120%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8364; million</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net cash provided by&#47;(used in) operating activities in the Consolidated statements of cash flows</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,526</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,522</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition of property, plant and equipment and software</font></td><td colspan="2" style="background-color:#f4f2f6;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,656)</font></td><td style="background-color:#f4f2f6;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,516)</font></td><td style="border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquisitions of intangibles assets, investments and other long-term financial assets</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(824)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,488)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Proceeds from disposals of property, plant and equipment, intangible assets and other non-current assets net of taxes</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,531&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">667&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Repayment of lease liabilities</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(291)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(149)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Others</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(803)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Free cash flow</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</font></div></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,483</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,096</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Most directly comparable IFRS measure to free cash flow.</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Transactions up to &#8364;500 million per transaction.</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> In 2022, includes upfront payment of $900 million and regulatory milestone of $100 million received as part of Libtayo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> license-out.</font></div><div style="margin-bottom:6pt;margin-top:3pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Non IFRS indicator (see definition in Appendix 9).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"><br></font></div><div id="i99a8229dc59741fa88b7606c304d7a60_437"></div><div><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  27                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><font><br></font></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Appendix 10&#58; CSR dashboards</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.928%"><tr><td style="width:1.0%"></td><td style="width:33.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Affordable access</font></div></td><td colspan="3" style="background-color:#23004c;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#23004c;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Sanofi Global Health</font></div></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2021</font></div></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2022</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Malaria</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:11.46pt">9,276,504 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">patients treated</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:11.46pt">23</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> countries</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:12.55pt">2,835,392</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> patients treated</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:12.55pt">18</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> countries</font></div><div><font><br></font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Tuberculosis</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:11.46pt">146,356 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">patients treated</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:11.46pt">28 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">countries</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:11.46pt">138,593 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">patients treated</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:11.46pt">17</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> countries</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">NCD</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:11.46pt">40,439 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">patients treated</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:11.46pt">16 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">countries</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:11.46pt">185,151 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">patients treated</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:11.46pt">28 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">countries</font></div></td></tr><tr><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Rare disease vials donation</font></div></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2021</font></div></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2022</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"># Patients treated</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">1,083</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">1,122</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">#Vials donated</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">109,677</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">121,025</font></td></tr><tr><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Global access Plan</font></div></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2021</font></div></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2022</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"># of access plan</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pilot phase in progress</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Global access plan initiated for 2 assets<br></font><font style="font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><br></font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.279%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#23004c;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">R&#38;D for unmet needs</font></div></td></tr><tr><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Eradicate Polio</font></div></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2021</font></div></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2022</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"># Inactivated Polio Vaccine (IPV) doses supplied</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">50.5 million</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> IPV doses supplied to UNICEF for GAVI countries</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">47 million </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">IPV doses supplied to UNICEF for GAVI countries</font></div><div style="text-indent:36pt"><font><br></font></div></td></tr><tr><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Sleeping sickness elimination</font></div><div style="text-align:center"><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2021</font></div></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2022</font></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"># Patients tested</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">2 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">million</font></div></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Data updated annually at Q2 23</font></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"># Patients treated</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">805</font></td></tr><tr><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Pediatric cancer treatment development</font></div></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2021</font></div></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2022</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"># of assets identified</font></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2 assets identified, preclinical studies started</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;1 asset pre-clinical assessment complete</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;1 asset in protocol preparation for clinical study</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;1 additional asset identified for clinical development </font></div><div><font><br></font></div></td></tr></table></div><div><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  28                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:20.129%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.129%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.811%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="background-color:#23004c;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Planet Care</font></div></td></tr><tr><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Blister free vaccines</font></div></td></tr><tr><td colspan="6" style="background-color:#f4f2f6;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2021</font></div></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2022</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">% blister free syringe vaccines</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">29%</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of blister free syringe produced</font></div><div style="text-indent:36pt"><font><br></font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">33%</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of blister free syringe produced</font></div></td></tr><tr><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Eco design</font></div></td></tr><tr><td colspan="6" style="background-color:#f4f2f6;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2021</font></div></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2022</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"># of Life Cycle Analysis (LCA)</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">4 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">LCAs completed</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">7 LCAs completed &#38; 1 in progress</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Eco-design digital solution launched</font></div></td></tr><tr><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Scope 1 &#38; 2 emissions</font></div></td></tr><tr><td colspan="6" style="background-color:#f4f2f6;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2021</font></div></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2022</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">GHG reduction vs 2019 %</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">-24.4%</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">-29.4%</font></td></tr><tr><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Renewable electricity</font></div><div style="text-align:center"><font><br></font></div></td></tr><tr><td colspan="6" style="background-color:#f4f2f6;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2021</font></div></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2022</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">% electricity consumption from renewable sources</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">51.7%</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">62.0%</font></td></tr><tr><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Eco car fleet</font></div></td></tr><tr><td colspan="6" style="background-color:#f4f2f6;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2021</font></div></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2022</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">% eco car fleet on total car fleet</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">26.2%</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> eco-fleet</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">34.1% </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">eco-fleet</font></div></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.698%"><tr><td style="width:1.0%"></td><td style="width:18.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.232%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#23004c;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:11pt;font-weight:700;line-height:112%">In and beyond the workplace</font></div></td></tr><tr><td colspan="9" style="background-color:#f4f2f6;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2021</font></div></td><td colspan="3" style="background-color:#f2f2f2;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2022</font></td></tr><tr><td colspan="15" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Diverse Senior Leadership</font></div></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">% of women</font></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">34.2% </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">of our executives</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">40.1% </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">of our senior leaders were women</font></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">37.2% </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">of our executives</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">41.7% </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">of our senior leaders were women</font></div></td></tr><tr><td colspan="15" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Engagement with communities</font></div></td></tr><tr><td colspan="9" style="background-color:#f4f2f6;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2021</font></div></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2022</font></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"># volunteers</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">4,975</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> volunteers</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">6,825</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> volunteers</font></div></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"># hours</font></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">26,906</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> hours</font></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">46,976</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> hours</font></div></td></tr><tr><td colspan="15" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">From Leaders to Citizens</font></div></td></tr><tr><td colspan="9" style="background-color:#f4f2f6;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2021</font></div></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2022</font></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">KPI</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Roll out planned in 2022</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">More than half of the leaders have completed the initial eLearning phase</font></td></tr></table></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  29                   </font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>chart-77caa408d3724fb9a48.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 chart-77caa408d3724fb9a48.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"@WQQ^*OCOXH^,/BZ8O#&KZL)M86*QN[?3K6V@:YGGW1H+E;AB@!"^86ZL:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+\.=3FU-+&ZAUBUB_P!9:3S*81,(YRGE29\U96558]/Q>_:S_P"#-7]J_P"
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MU^X?_!*7_@CW^RO_ ,$COA9J7@GX#)J.L>(/$<D4GBWQKK[(U]J;1!O+B"H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445^
M:OQ0_P""LW[4G@__ (.-O ?_  2KTG3_  H?ACXD\--?ZC<3:3*VJ"4:+?WO
MR3B8(H\VVCX,9^7<.^0 ?I5117\T?_!P%^W3^T]^T1_P6=F_X)Q?$G]J[5?@
MK\%=&\1Z'HL]W;W4MO90VUY;6LT^L7PC>/[4!]H8H)'$4:(O*'S'(!_2Y17\
MJ/\ P5)_9.^('_! 'XE?!SXP_P#!//\ X*;^*?$B_$&QO=0M)-,U5 1]D>V
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** /@C_@L/^S!_P %J_C]\0/!>J_\$KOVNO#?PVT/
M3M&N8O%MGKFJ/;M>W;2J8I%"V%SD*@8=5Z]#UK\./B+^S!_P6KT[_@O-X+^
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 45RGQ?^.7P?^ /A1_&WQG^(VD^&],3(6YU2[6,RL!G9&GWI7_V$#,?
M2OS_ /VF_P#@X@\ Z ;CP]^RA\+IM?N5RJ>(_%(:VLP>S);(1-*O^^T)'H:]
M7+<DS3-I6PU)M=]HKYO3Y;G)BL?A,&OWLK/MU^X_2NO&/C?_ ,%#?V+_ -GB
M2:R^*/[0F@6]_!D2Z3IUP;Z\1O[K0VP=T)_V@![U^('[0O\ P47_ &R?VG'F
MMOBA\;]5_LR;(.@Z-)]AL=I_A:*':)0/63>WO7B-?>X#PYT4L;6^4%_[<_\
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MM_X[_'[]F7X0?";]ABTU_P 6_"+XN6%WKGBC7?!FB7DCZS:VMQ"EO:EQ$3'
MSEY2&7]X8XSRJD-C>&_^#,OXU:G9V?PY^*W_  5?U>[\!V,X>/P[IO@^Y*%
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M/PB^.6J?!_XMPK;&^\1Z7IOVNVU.2V"BWN)(UFADAN8U2-%GCD!"QIE&*@T
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MXTU&)]3\8S>&QI;1V$*?N+*.#[1<%%$C2R,WF?O"ZY \M:^YJ /Q&_X/=O\
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MLZEMX+!3N6VBW*\T@Z*50'?)&" ?5U%?R2_L^?%?_@I#X<_X+Q?!;PO^VO\
M&'QI;>,O%/QD\&ZWXJ\.7/B&XCBABU2XLKV.UDM5<1P@07$:FV"@1#]V0-I
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBBRE256=Q;J !EEE"@C<#7[/_P#!$O\ X-VO^'.GQ]\6?''_ (;!_P"%B_\
M"4>#SH7]E_\ "O\ ^R/LV;J"X\[S/[0N=_\ J=NS:OWL[N,&3_@KG_P;;_!;
M_@I+\;K;]KGX1?'+5/@_\6X5MC?>(]+TW[7;:G);!1;W$D:S0R0W,:I&BSQR
M A8TRC%0: /QK_X.#O\ @G-\&_\ @B?^V9\+/$W[!GQ.\3Z'<ZOHK:_8VUWK
M7G7V@WUK=!([B&=55Q')_"'W'=%+\Q!VK^W/_!3'_@E1:_\ !<[_ ()^?"FY
M\<^-3X"^)VDZ%8^(M#ULZ<9H;2\O+&%KVRGA#*PBD8)DJ0R-#&P# ,C?.O[.
M7_!II'JG[2>F_M-_\%._V\_%/[05_I,T#Q:+J]O<E;_R#F**\O+RZN)I[<'_
M )8*$!'!8J64_L>B)&@CC4*JC"J!@ 4 ?BAXP_X(L_M?K\5O#O\ P43_ ."\
M7_!2'0OB%X$_9QT8ZW8Z1X<T,1O=6]DPNEAE?R+929)(H]YV2S7!"QEP2K#P
MS]D37/VB/&O[,_[8W_!SK\2+"2R\?>(-#U/1?@6)E\W^P+5GCL7O;?<""+9#
M#:Q/CG[+<[@1(<_KI_P6$_X)O_$?_@J?^R];_LI^%?VJ&^%N@WFO07_BV>'P
M>=6DUJ" [X;0C[9;B*,3;)B?G+-#'T"D-ZG:?L/?LZ6G[$R_\$^U\%C_ (5G
M_P (&?"+Z2LFV1[ V_D,_F 9\\Y,AE^]YAW_ 'N: /YO/!O_  2F^#GQ&_X-
MZ?%/_!9[Q5\6?&]S\<[?Q)-JUOKT_B-GC'E:[%IY23<ID>5UWS"8R;_,9.=H
M*G]W/^"!7[3/Q4_:\_X)&_!KXY_&S7+G5?%%[I%]IVJ:O>.6FOS8:E=V$=Q(
MYY>1X[9&=SRSEB<DYKX0E_X-/?VGM.^&VH?L<^$_^"P/B:T_9XU3Q"-5O/ $
M_@XO*S+*DJHP6\6)VW(C%P%C,B+)Y.X #]<?V4OV9?A9^QI^SGX/_9>^"FFS
M6OACP5HT>G:6MU*'FE ):2:5@ &EED9Y7( !>1B !P #T&BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\7?#_P ;?#R]_9R_:0\/-KWP_P!8?<4'_'SHMQSMO+1\$HZDDD#KEN"&97^
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN2+ZU[!7Y0_\&Z7[1#:;XL\:?LNZU?XAU.V7Q!H,3O@">+;#=*OJSQF!L#M
MQK]7J_G?B/+?[*SBK02]V]X^CU7W;?(_2<LQ7UO!0J/?9^J_JX4445X9WA11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGV?G^>ZT/S[%X2M@JSIU%K^#\T%%%%>B<P4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !7VY_P $ _$K:%^WJ=*$FT:SX)U&S*Y^]M>"XQ_Y S^%
M?$=?57_!%'4CI_\ P4H^'T6["W46KPM_X*KMA^JBO'XAIJID6)7]R3^Y-_H=
MN6RY<?2?]Y?F?O51117\YGZ6%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >7?MHJ6_9E\4 ?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^HKY_BJLJ'#V(EWC;_P)I?J>CE$/:9E37G?[M3]:J***_GL_1PHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*^.O!'CJ"6Z\$^,M*UB*W<)/)I6HQ7"QL1D!C&QP2.QK\@OVU?\ @L#^U/\
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MV1X-TV;6]0?;G_4KF,#_ &M^& [[#7F'BWQ+J/C/Q3J/B[6&!NM3OI;JXV]
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/_@YTC\<:Q:+#8^&9M7TQ/$.JR*TVZ."UACUF:=D\V3=\B[%+EF(!)K]A/\
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MH^.4%WX4^$MMXZMO!/P,\#70)+V,GVEY[I>=I(:V EG /G3,R*0ELJC]K/\
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MU_(FU4@55_H*/(QG%?/?[$__  3!_9'_ & ?%_CWXB_L^^$]57Q)\3-36_\
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MY9S5:V/DMO<CZO67W*WWG@YW6M&-)>K_ $$HHHK]A/G0HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "NX_9]^".N_'CXAVWA'3=\-G'B;5KX+D6U
MN#R?3<?NJ.Y/H"1S?@OP;XC^(/B>S\'^$]->[O[Z81P0H/S8G^%0,DD\  FO
MT5_9[^!7A[X!^ HO"^E[)[Z?$NKZCLPUS-CMW"+R%7L.>I)/Q_%_$U/(,%R4
MG>M->ZNW]Y^G3N_),]'+L$\75O+X5O\ Y'6>%_#.B>#/#MEX4\-V"6UCI]NL
M-K G1548_$GJ2>222>M7Z**_GF<Y5)N4G=O5L^N225D%%%%2,**** "BBB@
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MN%K^F.%\L_LG(J-!JTK<TO\ %+5_=M\CXK'5OK&*E-;;+T04445] <@4444
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M/V*OV!/V2?\ @GE\+7^$'[(OP<L/">DW$XN-3EBDDGN]2G P);FYF9I9F )
MW,50$A0HXKS#]D/_ ((J?L$_L.?M.Z_^U[^S[X&URP\;^);2_MM5O;_Q+<74
M+QWES'<SA89&*J3)&A!'0# ZT ?BG^WY:VUK_P 'FGA8V\"IYOQ?^'3R;5QN
M8Z9I&3]3BNU_X/A;6W3XV_L^WJPJ)9/"NO(\@'+*MS:%03Z LWYFOUV^)O\
MP12_8(^+O[>=E_P4D\:^!M<F^*FGZWI6K6VJ0^);B.U%SIT4$-JQME;RR EO
M$",8;!)ZU?\ ^"AG_!'C]AW_ (*A:]X8\2?M=>"]:U:Z\(6ES;:(VE>(KBQ$
M<=PT;2!A$1O),28)Z8]Z /;_ -FXEOV=_ 1)R3X+TO)/_7I%7:5G^%/#.D^"
M_"VF^#M!B:.QTG3X;*R1W+,L42!$!)Y)VJ.>]:% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4RZM;:]MI+.\MTFAE0I+%*@974C!4@\$$=J?10!\D_M._L+W&G&X\>
M?!#3WFMSF2\\/1Y9X^Y:#NR_],^H_ASPH^7Y8I(9&AFC9'1BKHPP5(Z@CM7Z
MK5Y!^T-^Q_X%^-D<NOZ4(]&\1%<C4(8_W=R>PF0?>]-X^8?[0&* /@:BNI^*
M?P9^(GP:UK^QO'>@26^]B+:\C^>WN .Z2#@_0X89Y KEJ "BBB@ KV'X"2'X
M:?!WQU\=I&\N[%F-!\/2;L-]JN,&1TS_ !1IM?Z!J\>KUW]IAC\.OAMX&^ ,
M&4GLM..M:^@QS>7&=J-WW1KO7_==:^BX5RS^U<^HT6KQ3YI>D=7]^WS./'U_
MJ^%E);[+YGBU%%%?TL?%A1110 4444 %%%% !1110 4444 %%%% !112QQR3
M2+%$A9F("JHR23T % "5V/P:^!?Q!^.?B(:%X*TO,49'VW49\K;VJGN[8Z^B
MC+'L."1ZS^SW^P-XN\</!XG^+JSZ)I!P\>G8VWER/0@_ZE?]X;O89#5]C>#O
M!7A7X?>'X/"W@S0K?3K"W&([>W3 SW8GJS'NQ))[FOSOB3CW!Y:I4,"U4J]]
MXQ_^2?DM.[Z'KX+*JE:TZND?Q?\ D<G\ OV<O GP \/_ &'P_!]JU.X0#4=8
MG0>;.>NT?W$ST0>V23S7H%%%?B>+Q>)QV(E7Q$G*<MV_Z^Y;(^FITX4H*,%9
M(****YRPHHHH **** "BBB@ KY"_X+Z?\H;_ -H7_LGL_P#Z-BKZ]K*\;^!?
M!/Q,\)W_ ("^)'@[2O$&A:I 8-3T76]/BN[2[B)!*2PRJR2+D#A@1Q0!_+=_
MP;W_ /!8G_@GG_P3/^#/Q"\"_MG_  3\2>*M4\3>)[:_T6XT/PAIVI)!;QV_
MELK-=W,3(2W.%!!ZYK]O_P#@DM_P66_X)^?\%+?'_B[X:?L7_!OQ1X5OO#NC
MP:GKCZWX3T_38KB)I3$@4VES*78,QX8  $X/.*]X_P"'97_!-S_I'S\#_P#P
MT^C_ /R-78?![]D_]EK]GG5+S6_@!^S5X \#7NH6ZP:A>>#_  ;8Z9+<Q!MP
MCD>VB0NH;D DC/- '\O7_!)_]N+X;_\ !&'_ (+6_%GQ=^V1X:\066G&/Q-X
M1UH:7IOGW%A</JD%PDQB+*7C)LPN5R2)58 BK7[1_P"V_P#"C_@HA_P<M_!3
M]J/X'Z#XAL?"VK_%_P"'=KI)\3:<MK<W26VHV4+3B-7<"-G1MIW9('(4Y _I
M6^-7_!._]@W]H_X@1?%?X_?L<?#3QEXFB6-/[=\2>"[*\NI$3&Q)))(RTJJ
M %<L . ,$UM:E^QE^Q]K/CS3/BGK'[*/PUN_$^B&S.C>([GP+I\E_8&TV_93
M#<-"9(O)V)Y>UAY>Q=N,"@#\!?\ @]V_Y.V^"?\ V3F]_P#2]J_HA7P[%XO^
M$8\)SW3P)JGAS[(\T?WHQ);["P]QNS6'\8?V3_V6?VAM4L]<^/\ ^S5X \<W
MNGVY@L+SQAX-L=3EMHBVXQQO<Q.44MR5! SS7>Q116\2P01*B(H5$1<!0.@
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MI5QK7[,/[1O@OQ[!9!3?_P#"*>([>]DM-WW1-'$Y>$GL' )K\C_C-_P;T?\
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MK^TG\'KJ\F\,>,=*34=%EO[0P3- Q(!>,DE#P>*_G?\ @!_P69_X-Y+>70?
M'[0W_!#_ $;0TM[&VM-6\36WAC2]1D$RQJKW$D#)"Y4G+MM+/@G"L>#_ $.?
MLL7/[.U]^SIX,U']DF'0H_AI=Z!;W'@I/#5N(;%;"1=\8AC 'EC#<H0"IR"
M010!WU?)G_!0+_@MS_P3F_X)I:RG@G]I7XWC_A+9+=9T\%>&;!]1U18F&5>6
M./Y+8,,%?.>/>#E<CFOH/]H;XKV_P&^ 'CGXY7EF+B'P9X/U/79;=C@2K:6L
MEP5)'3(CQ^-?R%?\$[OVD?A7XF_:_P#'O[9O[;_['/C/]J3QA<^;JVG>"[&R
M\_3[O4[B9GFO=2/ES8AB12L<)AEC/F<J!$HH _HZ_P""<O\ P<-?L%_\%/\
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M[@N"<[BG[-/[8'P3_:>_X*$_&#_@XX_;KU>\T[X&_!74$\'? ?2Y;)II]0U
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M0!]\?">]\5:C\+/#6H>.H6CUN?P_9R:S&Z[2ETT"&4$=B'+<5T%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMSZ7XA\6W=EX4T[5+60I+:)>R$7+HPY5S:QW"JP(*LX8'*B@"A^U[_P<Z_\
M!)/]C[Q]?_"W6_C#K'CG7])G>#5;'X<:+_:,=I,I(:)KF22*V=P00525BI!#
M8((KV[_@F7_P5>_9=_X*P?#KQ#\2_P!F"R\4VUGX7U2+3]7MO%>DQVD\<TD7
MFJ%$<TJL-O<-UK^;#_@E+^V!^QK^P5^SMJOQN^(G_!(O6/VC/&MUJTW]I^+/
M%EI''X;\-:>@58H;>26SO(Q.Q$CR2M'&V&5 V%;/[N?\$%?^"F7_  3H_;\\
M)>-(/V/?V9-$^"_C.RFMK[QYX$TS1[.U%VI!BAOHY+2.-+N,8\LR%$=&VAE
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M[PSHOA?X>7$O@G2ET&WB7PY<V\@C>RELL-%&T3;E,8W(1M9"R,K'\R_V+_\
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M'5[B,V%QX>L_$>F22Q,\0EAD8HX=AGAH%V[\;V&37Y8ZUXX\+_\ !3__ (.
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !6#\5/B?X$^"7PQ\1?&7XH^($TGPUX3T.[UCQ#JD
MD,DBV=E;0M-/,4C5G8+&C-M52QQ@ GBMZN5^.GP<\%_M$_!3Q?\  'XD17,G
MA[QOX8O]!UU+.X\J9K.[MWMY@C@'8VR1L-V.#0!^;7BW_@\+_P""/WASQ&=#
MT>X^*&OVHD*_VQI/@A$MB.?FVW5Q#-C_ +9YYZ5]Q_L+_P#!0_\ 9%_X*/\
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M?LB_##PCKUM%)';ZWX8\ Z=87D2.I5U6:"%74,I((!P0<&@#\7OAG_P:1?\
M!1#X':YK/B'X$_\ !7ZZ\$W7B"82:S<>$X-7TZ2_(9V7SVM[Q#+M+N1NS@NQ
M'4U^;7@O]A+]JC6O^"ZTW[!VF?MG:U9_%5/'%_IC?&E+Z^%ZUU%833277FB<
M7.YXT:,GS=V'.21D5_8K7F=G^Q9^QQI_QH/[2-A^R9\,X/B(UX]VWCV'P'IZ
MZT;AT,;S?;A#Y_F,C,I;?DJQ!.#0!\/_ /!5C_@K'\5/^""G[)?[/_A;6OAQ
M;_&3Q!JNA+X>\0:]K'B6>RDNKO3;"S26]+M%.\K3R.[G>=V3DEB363_P5Y^'
MOQ5_X+#_ /!N_I/QE^%WPWD3Q?K'A?P_\2-/\&Z9,UU(Q$*S7-I"VU6F=;>X
MN"@"[I&15"Y8"OT.^,?[.'[/'[1-I86'[0/P%\%^.H-+DDDTR'QCX6M-32T=
MP [1"YC<1E@J@E<9VC/2ND\)^$O"O@+PQI_@GP+X9T_1=&TFSCM-*TC2;*.V
MM;.WC4*D,448"1HJ@ *H    % '\]G_!!?\ X+__ + O[#G_  2U\0_LG?MC
MSZI;^(O"NIZQ-HGAF+PW<7L?BJTO,S?90Z1M%#)YKS1.+@QQ[60[FRRKD?\
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&BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>chart-8f98b6910d09426f888.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 chart-8f98b6910d09426f888.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MEXD\36]I-I<4CD*HN98)F>W4L0/,,9C499V1030!^L=%>6_MF?MA_!?]@_\
M9D\2_M;?'N_OX_"'A6&U?4I='L3=7#FYNH;6%8XP1N+33Q+DD !LD@ FORYN
M/^#V+_@GNGB<65K^R[\8Y-'\S#:B]KI2W&W^\(/MI4_3S!0!^S%%>/\ [#G[
M=W[-'_!13X"V?[1G[*_CO^V_#]Q<O:7D4]NT%WIMXBJTEK<PMS%*H=#CE65U
M96965C\%_MA?\'<G_!/;]E+XV>*/V?K#X1_$[QCK_@WQ#>:+KUQINEV=K8QW
MEK.\$\:27%RLDFV2-QGR@IQD,0: /U4HKX*_X)A_\'%?[ G_  5&^(X^!GPV
M/B7P9X_EM9+BP\*^-K*&)M42)"\OV2>"66.9D0%S&Q23:KL$*HS#[UH ****
M "BBB@ HKYZ_X*F?M[VG_!,O]B7Q5^V5??"Z3QE%X8NM.A;P]%K L&N?M=]!
M:9\\Q2[-OG;_ +ASMQQG(R/^"1__  4ALO\ @JK^Q]:?M9Z?\()? \=UX@OM
M+_L*;7!J+*;9E7S/.$,.=V[ILXQU- 'TY1110 4444 %%%% !1110 4444 %
M%%?E=^V1_P ';W_!/?\ 9+^.'BK]GBS^$GQ.\8^(O!?B.]T/Q!/IFEV=K8Q7
MEI.]O/&DEQ<K))MDC<;A$%.,AB#0!^J-%? __!,7_@XQ_8#_ ."H?Q*7X$_#
MK_A)O!?C^>VDGT[PMXVLH8CJJQ(7E^R3P2RQRLB N8V*2%59@A5&(^^* "BL
M_P 6^+?"W@+POJ/C?QQXCL='T;2+*6\U75=3ND@M[.WC4O)-+(Y"HBJ"Q8D
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MPZ]PLY@$%O<+=M-*[ND^PF!59;:5@V I8 ^J**** "BOD[]M_P#X+5_L$_\
M!/+X^^'_ -FC]IOQSKFF^*_$VBVNJZ3:Z;X:N+R*2VN+J>UB9I(U*J3+;R@@
M\@ 'H:^L: "BBB@ HHKYX_X*(?\ !4C]C;_@E[\-;7XC?M7_ !&>PEU5Y$\/
M>&M(MOM6JZRZ %Q;P @;5W+NDD9(E+*&<%E! /H>BOQJT+_@]>_X)Z7WBI=.
MUS]F3XP6&D/+M&J+::9-*BD\.\ O!@=R%=CZ9Z5^I'[.O[8/[/7[4O[,VA?M
M?_"7X@0R?#_Q#827=EKNKPOIZQI',\$HE%P$,12:.1"6X)7()!!(!Z;17YZ?
MM,?\'+G_  3O_9U_;%T#]B_1W\0_$76]<N].LI?$7P[ETZ_TC3[R\N3 MM-.
MUVA,L?R/((U<*) ,EPR+^A= !17YH_\ !0;_ (.G?^"=W[!OQJU7]G>VT/Q=
M\2?%?AZ[:T\1IX-M[86&F72'$EM)<W$R;YD/#+$KJK!D9E=64>@?\$N/^#AG
M]@[_ (*H^.9?@S\,3XB\&^/X[.2ZMO"/C2UABDU**-=TKV<T$LD<^Q?F9"4D
MVAF"%49@ ?=U%%?+'_!4W_@KI^S=_P $B_A_X5^)'[2/@GQQK=CXNUF;3=-B
M\#Z;9W,L4L<7FLTHNKNW"KMX!4L<]AUH ^IZ*_('_B-6_P""67_1 _V@/_"6
MT/\ ^7%?9O\ P2L_X+&?LR?\%>O#?C+Q3^S7X%\=Z';^![ZSM=63QSIEE;/*
M]RDKQF$6MW<!@!"V=Q4@D8!YP ?6-%?D7\?/^#R7_@G-\(_'NI?#_P #_!3X
MJ>+YM)OY;2\U*#3+*RM'>-RC>49KGS6&5/WHTKZ>_P""7/\ P7K_ &$_^"KV
MNW_P\^!^H>(/#?C?3; WMQX+\9V,5O=SVRD*\]N\,LL4Z*67(#B0 @E .: /
MM:BOAK_@J-_P7_\ V./^"2?QCT#X(_M'?#7XF:UJOB/PRNN6-QX)T;3KFW2W
M-Q-;A7:ZO[=A)O@<X"D8(^;.0/F;_B-6_P""67_1 _V@/_"6T/\ ^7% 'Z_4
M5Q_[/7QK\*_M*_ +P/\ M&>!=/U"TT3Q_P"#],\1Z/:ZM$D=U#:WUK'=1),L
M;NBRA)5#!7=0P(#,.3V% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX.(='\>?LAZ>GAK2;/7]!\7:3H&DCRX+.*[(2]L$1<!;>4K<IY0PJQ3^6 %
MKZ6_X)*_\'6'P@_8<_8ST7]CC]N+X!?$*Z\1_#.T?1M U'PK8VLC75I$S"&V
MNXKNXMVMI801#D!P5C4D!@0?$OV5?@O^T_\ \')G_!:D?MO^*_@_>^'OA+I7
MBG3[WQ!?3*SV.G:1IWE^1I$=PRJMQ=SB)5<(,JT\LI54 6@#]>?^"]'_  5S
M\4_L5>"]%_8W_8XL9?$?[2?Q?*:=X'T33(Q//HL$[F$:@\?3S6?*0*WREU:1
MLI"RM^#W_!<O_@E;9_\ !+3P)\ _"?C+Q/+XA^)_CO0M;U[XI^(I+QYDN-2:
M>UQ!$SG+1PAW7S#\TKM)(<;PB?L[_P %.O\ @V._X>+?MSZW^W!I/[>.K_#O
M4M6T^PM8-+TOP1]JDM/LUFEL66Y6_A;YPA) 48W$<]3^,/\ P7[_ ."3/B;_
M ()3>/\ X;^%/$O[7NN_%MO&.CZA=Q7>N:.]HVG""6%#&@>[N-P?S,DY7&WH
M>P!_5]^S-_R;?\/O^Q(TG_TCBKMZ^-/^"&/_  3\US_@GA^Q1#X!UW]HG5?B
M._C35(?%D.H:MIS6SZ;'<Z;91BQ0-<3;D3R"P8%0?,/R#&3]<^,_%.G^!O!^
MJ^-=6AFDM='TV>^N8[=09&CBC:1@H) +84XR0,]Q0!\\VW[$_P#P2M_X)^_L
MT^(M4O\ ]FSX8>$?A[H>CSW?BW5-<\/6]T9[8 F1KNXN5DFNV;.T"1G9BRHH
M)(6OP5_X-<?@GK?QS_X+?^(/VGOV??!5[H7PK\#KXBU">)E(AL[+44N;;3=,
M9LD&3$RN%R<BS=OX:\)_X*Q_\%Y/C'_P5P^+VG^#OB9=:UX#^ FEZTDMMX%\
M+F.XO)XE;_C[NC(\<=U=[<[%8K##GY03N>3]*?\ @CE_P<"_\$NO@[K'PP_X
M)L?L:_L-_$'PG:^,/%UAHRZWJU_I\TUYJ-Y+' =0OY4DWS2$E2Q PJJ$1515
M0 'R+_P4/TVR_;1_X.U+#X.?&2U75/#"?%SPKX<ET:]&^%]+MX+-YK7:?^6<
MS>>S#N;A_6OI;_@]5_9H^#G@_P"$_P #OCIX(^'NC:)K4>NZAX>NKG2=.BMV
MNK(V\<\,3^6HW+$T3[ ?N^<^/O5XG_P<+_!3XV_\$T_^"Z/A;_@JIH/P[N]4
M\#ZYXK\/>*=/O8486K:CIZ6\5WI<TP!$4DJVID&>J7)*Y\MPO%?\%W?^"POA
MS_@O)XO^#'[+_P"P=\!?'MP^F:E=3G3-9TR#^T-5U:Z6***""&VFF'EQ(DA,
MC,,^:20JQ[F /VT_X)H_#_X<?\%'/^"&?P2^'W[7/A!/&&@:[X T2'7M,U*Y
ME5=1;2;N(V[3-&RL^9;&&1@3B3!#AE9@?%O^#D/PM_P3:_9/_P""1?BWP#XA
M^ GP[T/6->MH]*^$VAZ)X8L[2ZCU021L+BT$,:M$L$8,DCKA=G[MB?-56],^
M,/[0-O\ \&]O_!#[P/J7B3P"WC'7/A[X1T7PVNEV5XL-M=:Y-&!+(\I!*VXG
M\YR55F*X '.X?SD77_!2/P+^W!^W6/VN_P#@LDGC?XCZ'98;3?A_X%EAL[)8
ME?='IZ&693:6:]6$>9I226E#EI& /V<_X,N/V=OBU\,OV)?B-\<_'.GW5CX?
M^(WC"V/@^VNE*BYAL89(I[V,'JCRRF(-W-HW8 G](O#'[!7_  3U_9T_X3;X
MN6W[-_P]TB7Q#J>I^)/'GB[Q!I4$\UQ)<2RW5Y/<WEWO=80SR/L+B*-20JJH
MQ7S1_P $8?\ @NO^RY_P4\\<ZM^S'^S=^S1XB^'ME\/_  9#>V=KJ LDLH;*
M.:*UCMH([9B(PH=<+@*%7 K\6O\ @N[_ ,'!_P =_P#@H1\2M<_9+\!'4?AY
M\$]$\0R6&K:78LLNI^(C;SE&GO2KJK1@H7CM%<1[@"[NP1D +W_!-+X8^$OV
MRO\ @YN7XG?L ^!_[&^%?AGXHWWBN*?2K$VUE8:%;,X+B, ""*ZD*QQPX&T7
M2IM4*0O]4E?SL?\ !)?_ (.!/^"2W_!.?X=Z)^S%^S/^P_\ $]-2\3:I9P>)
MO&NKWFF/?ZY>NXB6>X=9?EC0NVR%,)&I; +,[-_1/0!^0?\ P=&?\%K?VJ/^
M";8\"?LZ_LA3VWA[Q#XXTBZU75?'-UIT5U+96L<HA2"TCF5HA*S;R\CJQ10F
MT MN7YZ^"OPQ_P""]/Q0\"V7QJ_8=_X.#OA9\9O%SZ>-0N/AW8>-;:[E9BF]
MK98+RW:(2#.TK/';A>Y6OHS_ (.//VK/^"7/A_XV> ?V1/\ @J?^RKXJ\0^&
MM5\)R:[X4^)_@:\":IX<NWNI+>>%4+1[XF2&)W&^0$A,P,51A^&7[87PE_8&
MM?CYX T+_@B+\6_C=X]U[5;]S_9_B#0!#J5C?AXC9K82VL4,LLA/FDXB!38A
M#L2=H!_2K_P5S^&W_!6'XI_"3X96O[#'[6GA;X*1VMO=7'QD\6^*=0MK2WMU
M\FU\D+*;:=T(D^T_ZHHIR-SXVD?C5^V+^W1_P5J_X)=ZIX>^(_P__P""^OPW
M^/GVK51::CX<\*>-;3Q#-9LJ-(?M5E-'(%@8*R>:K!@Q ^0E372?\'8%S^W%
MHA_9<\(_M/ZKKD_@Z/X.:5_PEKZ?-_H5YXV0NNL.2O[IYQ$(#&6SA7<IPSU\
M_P#_  5F^(/_  0Z\6_L:>$-%_X)+?LK^-=&UK3_ !E9GQC\0?$.EWIC2)K"
M\QIL]U<W,JFZED F$<8"%;60J<+B@#]8_P#@LU^U1??MN?\ !JU-^U=J_A^#
M2K_QQHOA+4=3TZU9C#;W9UNR2=8]Q+>7YJ/MR2=N,DFN9_X(!_M@^"_V!/\
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M$M8TB?[7J\DFD26"V 41D"1+E9$9'*[/.W'"[B/L;_@S-_8<^./P#^ OQ/\
MVJOB]X3O]!TSXI3Z1;>#;#4H&AFO+*Q%V[W_ ); 'R9'NPL3$#<(G895E8_J
M)\7?^"<W[ /Q]^('_"U_C?\ L5?"SQ;XE+*TVO>(? EA=W4^T87S9)(BTP &
M '+ =J /P7_X)S?MJ_$O_@E!_P &TWCSXE0R7FF^-?C?\6]3TWX(6S!A,XDT
MZRM+G5H5Z[(3;W&U@"IFBA4\2"O>/V._VTOA-_P;L_ 'P#_P3K\)_LJ^,OC5
M^U/\2[.'Q?\ $7P7X-3$]G>WD/F6^GRRK'-*TL-JBCR8XI -LLQ*B4;K_P
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MO1$\16?PLO-/OK!(8M7#7]M;76H2W[11W#QMD))*44NK-L50Q9LL?RZ^&?\
MP>6_L,_"+]EC0/ 'PZ_8.\<:/XC\.>';?3=(\$Z9=V$7AZS$$2QQ017OFF<0
MJ% !-J6P.YYK] ?V8O\ @IWXQTK_ ((RZ=_P5%_;C^&>JZ;?0:)J6N^)O#'A
MC1/)N8;0:M<06L=O!>2QY'V?[.5:20;U._<=PR ?S\?\%'_V /@5_P $T_\
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M'C-]/T+4;S3[[7O*EO\ 2-3T^ZBAN+8SH 9HG5Y,[R^UH5V$!FS#_P &./\
MR3C]HW_L-^&?_1.I5X5_P;V<?\'-7Q?Q_P _?C[_ -.E ']+%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 ?%/_  6U_P""0O@K_@JE^R1K'PW\'67AGP]\3+:_MM4\*^,M0TE [7$
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M^K07NNVM@L-N]H8U8-<.@;YN,#)K]/J* /F7_@GM^Q!X5^$/[$_P/\ ?M%_
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M## @Z*B( J@>@&*MT4 %,NK6VOK:2RO;>.:&:,I+%*@974C!4@\$$<$&GT4
M>=^'_P!D+]DWPGXJ'CKPM^R_\.],UM91*-9T_P %6$-T''1O-2(/GWSFN[UC
M1='\1:9-HOB#2;:^L[A-EQ:7D"RQ2KZ,C AA[$59HH Y#_AGOX!_]$/\'_\
MA-6O_P ;K;\+>!_!7@:UELO!/A#2]'AGDWS0Z5I\=NLC8QN81J 3CC)K4HH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P '.'_!<?\ 8#N-*^&'[8GP4M==M].B2T-C\4_ %WHFK20Q@*%6>+R,R!0
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MJD5O/)<WIB*M/;P174:B Y7,,C %F7'LWP\_X*3_ /!7C]KCXP>"_AQ\#/\
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MQ#$UG!-9>&)-86^L%E,EO*Z6L<D^G7D0)5RT31'?(!Y@VNOV%^R?_P % /\
M@K'^V1^V%\,_#/A#_@AI:_ _X<VWC&SN/'WBWQ+X&D6[AT^.3=*;>ZO[:SC0
M@#_EE%)-D#85/4 _9NBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP]A^)'PJL_A'^T+X>CPMU!I&HR>&/$5M)C)BNH9]UM"^.@7(;DJ64@GOX_\
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M/PET.6X:XU&XTG5-0G6* ;IE29-0MC=,B\,T-N0I!R."!]Q_\$(_^"\?A/\
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M,^*+C0KN\2YM[_6H=3M&5;:*21HY8 1N52JR0["00<?T*^$?!7@WP!HJ>&_
M?A+3-$TZ-V>.PTBPCMH59CEB$C4*"3R3CFN?^+W[.'[//[05O:VGQ[^ W@SQ
MO%8L391>+_"]IJ2VY/4H+B-PF<#IB@#\6/\ @TX\,>*/C!^W7^UI^W7X2\+Z
MAIWPU\7:]<V_AZ>ZMC%'<S76JSWRQ)V9X("@<#.S[0@_BK]VJS?"/@WPA\/_
M  Y:>#O 7A73=$TBPC\NQTK2+&.VMK=,YVQQ1@*@R2< #K6E0 4444 %%%%
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M-G$[@$[6D9<Y4T ??=%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC325=;75]-@O;82##".6-9%S[X85I4 >??M)?LM_ W]K7X>2_#/X[>!;;6;
MDR65P?W=UI\V.)[:9?GAD''*GD<,&4D'YDC^)O[7?_!+R1=*^/LNL_&7X%0,
M$M/B'9VYF\1^$X.PU*)>;R!!UN%^8 $G'R15]N4DD<<T;12QJR,I#*PR"#U!
M% '/_"SXL?#;XW>!;#XF?"3QKI_B#0=3B\RRU/3+@21N.ZG'*L#PR, RD$$
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MV=P&=9YX5";('&0Q.2O')(_K8\<_"3X5?$][9_B7\,O#WB)K(.+,Z[HL%V8
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MX13PQ=7T#1IK<\E[;W,\T /^LCA^R)&9!\I>8JI)20+YS_P; ?\ *P=\:/\
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M"BBB@ IT,TEO*L\+89#E3[TVB@-SSGXJ^ H-#G'B;0("NG7,FV6 <_9)CD[
M>Z-@E<\C!4YVAFXVO>2()8);.\MTGMKB(Q7-O)]V5#@D'\0"".58!@00"/(_
M'W@FZ\%ZL(E9IK&Y!>PNO[ZCJK8Z.N0&7W!&592?H<OQGMH^SF_>7X_\$^"S
MO*G@ZGM::]Q_@^WIV^XPJ***],\ **** "BBB@ HHHH **** "BBB@ HHHH
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M^"U_]LTK0?%/B6/2[GQY>!F03>6[*_[[:P+8!M[;*CRYKAC7Z=?\$9_VR?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M ,$Q/"'B"31?A_\ "/XN>+K>)R#J]IH5C9VTH[&,7%VLQ'^_&AKZ@_X)C?\
M!?K]@/\ X*I>+;CX6?!#6/$7AOQQ;6+W@\&^-]-BMKJZ@3'F26\D,LL,X3()
M4.) N6*!0Q'SS_P49_:"_P""0W_!O!X0\ _"/3/^"7WA[Q!:^/--U(V1TO0]
M/FF<69MD<7MW?B2XN"WVE<,[2'"G/:O@#_@V4^!?P^_:V_X+,>(_V_?#&O\
M@7X::1X;U/Q#K7A3X+Z3KL1U$1ZC%<VRV]O:J$/V*VAO&#2A5&Y(E6,*QV@'
M[-?\%/O^"WW['/\ P2LUKP]\//C':>*/%7COQ7;BXT'P'X&TR.ZU"6!I#$D\
MGFR1I%&\JM&OS%W9&"(VUL9G_!,O_@O'^QK_ ,%/OB+K?P+^'>A>,/ WQ%\/
MVLEU>^!_B!I45I=S01NJ2R0-%+(C^670.C%)%W9V%06'YM?\%0_&GAC]C?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** /P+_P"#HW_@M1^R9\9_@/\ $?\ X)<>%/"WCF+XB^%_'VGIJ.H7
MVD6J:2YM)1)+Y<RW32G(8;<Q#)ZXJW_P:T?\%GOV4/A=\"OAK_P2M\1>%_'$
MGQ(\1^,]5^P:A::1:MI"_:'DN$WS-<B481"#B(X.!SUK]M=?_9O_ &=_%6LW
M'B+Q1\!?!>I:A>2&2[O[_P +6DTT[GJSN\99C[DTOA[]G+]GKPCK5OXD\*?
M?P9I>HVC[[2_T[PO:030M@C<CI&&4X)&0>] 'AO_  5"_P""NW[,/_!)/PAX
M3\:_M->&_&6I6GC+4KFQTI/!VE6UU(DD$:2.91/<PA5PXP06YSP*_FI_X(Y_
M\%1OV=?V!/\ @JSXO_;;^-6@>++SPCKUAX@ALK3P[IMO/?JU]>1S0[XY9XT
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MA_9A_9Q\$_#Y-=M?%+:TO@WPS;::+\PMI/E&;R$7S-GFR;=V<>8V.IK]G?\
M@DS_ ,$__@S_ ,$Y_P!B/2M"^!WPLU30-<\5>&].\0>--(U>_NIYI-=.FPK,
MI2=BT!WJ5,2[0I!& :_"C_@L&?\ @NK_ ,%C+WX?WWQ>_P""0?CGPDWP]BU1
M-/7PWX.U-Q="^-H7\SSMV-OV1,8Q]XY[4 ?T4_\ !/#_ ), ^!G_ &1WPS_Z
M:K:O8:_-;_@@]^UQ_P %0OB8+/\ 99_;:_X)Z:C\)?!WPZ^%MA8^&_%6HZ+?
MVLFJW-I]EM$B<W!\LNT(>0A0#E3CBO&_%7Q%_P""[\?_  <'Q>$=&T_XK_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ.LVD*_:;5&,1DAX4;I)0L8=>@!;+*"!]Q0?4R_'QI/V=1^Z_P /^ >1G/\
M9^-7UC#S7-U6U_OMJOQ/#:*U/%?@GQCX$U$:3XU\+:AI-RR[DAU"T>%G7.-R
M[@-R^XR#677T*:DKH^:"BBBF 4444 %%%% !1110 4444 %%%% !1110 5_0
MC_P3KUJ37_V%OA3?2/N,?@BQML^T,8A _)*_GNK]]?\ @E3*TW_!/CX8.Q/&
MB2KS[74P_I7P?'\4\MI2_O\ Z,]++'^]EZ'T'1117Y.>T%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%?/\ _P %._VXM6_X)R?L<^(_VP++X'WGC^R\*W-G
M_;6B6&L+92Q6D\Z0&Y#M%+N"/)'N7;]TLV0%- 'T!17R1_P1U_X*V?#7_@K_
M /L\:W\</!'PZN?!U]X<\42:-K'AB^U9+R6']S%-%.)%CC!CD60@?*/FB<<X
MS7B__!7[_@XL^&'_  2B_:/\-?LOI^S?JWQ*\2:[X<BU:ZATCQ&EF;$37$D-
MO 5,$IDDD,3MM&" 4.#O% 'Z/T5G^$=2UW6?"FF:OXH\/#2-3NM/AFU'2A=B
M<64[1JTD'FA5$FQB5W@#=MS@9Q6A0 4444 %%%% !17QO_P6(_;;_;[_ &*/
M ?@KQ#^P5^Q'??&S4]=U>ZM_$.G6.AZA?'3((XD:.4BR&Y-S,RY;@[>*]\_8
MU^*?Q?\ C?\ LL> _BY\?OA9+X(\:>(?#=O>^)O",]I- ^DW;KE[<QS_ +Q"
MIXP_/K0!Z91110 4444 %%%% !1110 4444 %%%% 'Y0_P#!7>R^R_MDWT^,
M?:= L)/KA&3_ -DKYAK[#_X+3Z!]@_:3T#Q!&F$U#P;"C'UDCN;@'_QUDKX\
MK],RJ7-EU)^2_#0^>Q*MB)>H4445Z!@%%%% !1110 4444 %%%% !1110 44
M5?\ #'AC6O&.N6_AWP_9F>ZN7VHHZ =V)[ #DF@"QX&\$:]\0?$4/AOP];;Y
MI/FDD;[D,8ZR.>RC/XD@#)(%?6?PZ^'FA?#7PW'X?T2/<?O75RRX>XDQRQ_H
M.P_.JOPH^%NB_"SPX-*L LMW-AK^]*X:9QV]E&2 .W)ZDD]16;=V2WT*NM:%
MHGB739-%\1Z-::A9RD&6SOK9)HGP<C<C@@X/J*\7^)'_  3^^!7C59;OPQ;W
M?AF]<.5?3I?,MR['.YH9">!V6-HQ7N5%:TJ]:B[PDT3<^$OB1_P3W^-_@XRW
MGA$V7B:R0L5-E*(;D(!G<T,A R>@6-Y#7BNO^'/$/A35)-$\4Z#>Z;>Q &6T
MU"U>&5,\C*. 1^5?JO6?XF\(^%?&NFC1_&'AJPU6U#%EM]1LTF16QC< X(#8
M[CD5ZE'.:T=*BO\ @_\ +\@T/RKHK[D^(G_!.GX,>* USX&U+4/#-R0H5(G-
MW;#!Y)CE;S,GVE ']VO _B/^P9\?O BR7FD:+!XCLT!;S=#E+R@9P 8'"R,Q
M'.(PX'K7JT<RPE;3FL_/3_@#L>+T5/J>F:EHNH3:3K&G3VEU;N4GMKF%HY(V
M'565@"#[&H*[DTT(**** "BBB@ HHHH **** "OW^_X)?V#Z;^P%\+K>1<%O
M#8EQ[22R./T:OP!K^BS]B[PVWA#]D+X7^&Y4VR6O@#2%G7TD-G$S_P#CQ-?
M^($TL!1AWE?[D_\ ,]++%^]D_(],HHHK\I/:"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[,\7_LT?LL^$_P!E#XU_\$\/'&K_ !:\$>&K7P[96]K=FSBU9K2%+>&2:&2
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M_;T^&^@M!O@T_71K%T2,JJ62-=#/L7B1?JPK]^J_+?$'$*6*H4%]E-_>[?\
MMI[&60M"4@HHHK\]/4"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>B>%OB)+'?CP[J7AZQN+)9KNR5Y+K3[NTN))&AN$CBF<,& _<.A16P3\%?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@*!T '85\MGN:J,7AJ+U^T_T_P SU,#A+OVL]NG^8ZBBBOD#V HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS]X*9$!_WA7F_P 8_P#@ME_P2C^ 7CR#X9?%;]N?P-IVN3I&S6,%Y)=_9A(
M5$[VZ2);$A@<2E" 02 .: /J6BL_PIXL\+>//#&G^-O!'B2PUC1M6LX[O2M6
MTN[2XMKRWD4-'+%*A*R(RD$,I((((-?+_P =O^"YO_!)3]FOX@77PL^+_P"W
M-X.LM?L+AK?4-.TPW.IM9S*<-%,UE%,L3J>&1R&4@@@$4 ?6%%</^SY^TK\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM^P!^UIX5NO!UY?//#%:Z]:2V.YN#,;#6;5X[>9@!O,08D@?.^ :]A_X(O\
M_!NQ^WU^RC_P4;L_^"DW[:_QJ\!S:L;C7+_5-"\-R2W5WJ%[J5M<12R2,L$%
MO;_O+EI,1;UXV@*#P ?GI^V%^T!\1/VK/^#C_P >ZK\5?V/-=_:3M_ GQ UW
MPYX;^"-CJTMLM]8:1]IMX$7RX)R(5:%KV2,1E96,F_Y7?-S]O[]E7]NW]I'X
M_>"_VB/V(?\ @WZ^)/[,FL^$T226'P1IUQ<075[#.LUK>QQQ:?:I;31D$%E5
MM_R$X*\_I'_P5=_X-R/VD_B+^W"?^"G7_!*;X_Z9X$^)EQJ*:KJVBZO=R6:_
MVDL?ER7EG<QQR*#,N1+;S)Y;EY27*R&,<AXA_9!_X/#/VJO#[?!KXP_MD> _
MA]X>NU,&KZ]H]_86-W<0XPQ672;(W"DC/RHT(;.&('0 \%_X/1]6\0:_JW[+
M6N^+-*:PU6]\#:U/J=B\91K>X=M-:2,J>5*L2,'IBM7_ (+/?\$)?^">?[(?
M_!%;1/VNOV??AKJ^E?$#3U\-W&J^(;SQ3>W;:JE]Y44R2P2R&!/GF#@Q1QD%
M<<@D5]:?\'&__!$7]LO_ (*HZ[\&;_\ 9FUSP:J> ?#^IV6NR^*];FM&EEG:
MT*-&$@EW ^0Y.2,9'7-?1?\ P5O_ ."=_P ??VW/^"0Q_8=^#5YX?B\:?8_#
M<7FZUJ,D%ENL9K=Y_P!ZL3MC$3;?DYXZ4 ?F[^S?^V#\;_V?_P#@S:UWQY\.
M_%U_::]:Z]?>%-%UB"=A-I=E>ZZL4QC<?,C"*XG1&!!1G0J1M%?*7_!'\V6@
M_LA:EO\ ^#;35?VJCXBUJ\CN_BG+JDI1$"K&+.U TNX^R-%R3)%*LA:3<2,(
M%_9K_@G)_P $6];\ _\ !%+6?^"5O[>!TFZ;Q+>ZJVJ7'A'4FG2V$UTMQ:W,
M,DL2?OH98XI5W(5#QC(89!^)/@;_ ,$:/^#DO_@DKJVO_#[_ ()J?M3^!O$W
MP_UK4VO%L;Z6UC663:$%Q)9ZE Z6LY1$#&"9@P1 S-M   G_  :A?LK?\%$/
MV/\ ]M[XF>'?CC^RG\2/AU\+?%_@2>ZAA\6Z1<16JZI;7]L+-/-D1%DF%M/>
M+D*I< G  P/A;_@D=_P3;^$/_!4[_@K;\6_V:/CGX]\6Z!X;MK'Q'KEX_@V^
M@M[F]:#6K6-+=VGAF3RBTX<@H3NB0@@C-?N3_P $DOV1/^"V/@G]J#Q+^U/_
M ,%9?VL]#\56NI>"9M#\.^ _#VI$V^F3R7EK.;G[-;VT%G&P2W,>]/,D8/\
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M@MY]0M[,SQVL2)O7S)I#F&*,1 '<@!W'_!N=_P JTW[2'_7[X]_]1JSKQ_\
MX,[?B+J7P?\ V;_VUOBWHVGK=WGA;PKH&KVEHX)$TMM9^()E0@<X)0#CUK[]
M_P""1_\ P28_:D_8B_X(Z?%_]A+XRZAX4E\;>.;GQ0^BRZ+J\L]BHU#1[>S@
M\V5X49?WL3;L(<+@C/2N9_X-MO\ @B_^U+_P2NT+XWZ!^U[)X+U&V^)*:#%I
MEMX;U66^C>*T74UN$G$L$8 87D8 ^;<-V<8Y /S*_P"#:3]@_P""/_!8#]L_
MXR?'_P#X*&"Z^(MWX>L[75;G2M7U.9!J^IZC<3[KNX:)T>18A;L!'D)F9,@A
M0M?NA^R+_P $4_V%/V#/VN]4_:\_9&\"WO@N^UWP-<^&=8\+6>I23Z7*DMY9
MW0NHTG+R0R@VBH51Q&0V=@8$G\S?$O\ P;C_ /!57_@FG^UOK/[2_P#P1$_:
M9T"#1-76>&'P[XDO$AO;:RDD$G]GSI=0RVM]"A5=DKE) 54[0PWG['_X))?L
MF_\ !<'0?VO=>_:X_P""MO[26@:Y87'P[N?#GAKP+H&IH8]/N)KZRN3<_9K2
MWBLT.RU9#(&DF;> 3M H _,K_@RB_P"3_/B__P!DG;_TZV=>6_!_]CGX'?MZ
M?\'4'Q2_9F_:.T:^U+P?K/QE\>W.JZ=8:E):/<_96U"YCC,L1#JIDB3=M*L1
MD CK7Z0?\&Y7_!"C]M?_ ()6?M3>/_C'^TWJO@>XTCQ-X&.D:<OA?79KN87'
MVZWGRZR6\85=D3<@GG'%'['?_!"C]M?X$_\ !P7XJ_X*=>-M5\#O\-]9\<^,
M-7M(+'79I-3%OJ<5ZEL&@-NJ!@;B/>/,..<$XY /S*_X+\_L,_ 7_@DW_P %
M9/A=HG[#NA7_ (1T>[\-Z%XMTZP.M75XVFZFFK7<.Z&:YDDFV_Z'#(-SL0S-
M@@8 ^E/^#UO]I#XG7G[1GPA_8\M]4O8_!L'@_P#X2N[TNUG,<>HZA<7MS9HS
M\$,T4=JP0D'9]I<X^:OI_P#X."_^"$O[;/\ P4Z_;M^'O[1W[-^J^!X/#WAC
MP'8:/J2>)=>FM;@W$.J7MTY1([>0,OEW$>"6!SD8XR?H3_@O1_P0L\-?\%A/
MAYX>\1>"?']IX0^*'@B*>'P[K.I6[R6.H6DQ5GLKORP9$4.H=)4#F,M)\CAS
M@ _(S]M_X ?%C]I?]DZR_9Y_9[_X-3/&OP;\1Z/<6CZ+\1]&N+F^U )$0)4N
MR-)@DOO-CW F68E7*N,E<'W_ .+?['G_  5A^./_  :P>$/V:KGX1^.[?QY\
M/_B&?[?\":A831:QK'A2U>[:WMTMV^>X6)Y[1TB )*62A02B@]GX!_9?_P"#
MROX5^![/]GOPK^T[\/KC1-,LET_3O%>HW^DWD\-NH"+_ *1<6+74A"CAY$:3
MWR!CZ'^('_!,[_@M+IW_  3!^&?P@^$7_!0.R3]HWP5\2KWQ9XB\=WOB?46M
M=:AN/M^; S2V[M.B_:H@(YX/)/D@;5 7 !^)W['_ .W5_P $X?V7/A!:?LJ?
M\%%O^"(-AXJUFT>=-<\=#7;O3/$,RO,[ M!.BO&Z*0@\N>%<1CY0237])G_!
M%[6/V,]7_P"";GPZ/[ .KZY<_"R)-1_X1^U\42!M2TUY-1N9[BRN<?QPSRR1
MCELHJ-OD!$C?E]^U;_P3=_X.D?\ @II\,;+]E7]L?Q/\$;?PE%JL%W=>))18
M1S.\1R) UG;/,A[E8HXMWW6^4D5^KW_!+#_@GSX1_P""87[%'A7]D;PKXNF\
M0RZ.UQ>:WX@GM_).HZA<2F6:58LMY<8)"(F20D:Y+-EB ?1%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4#VB,,,V0#]4Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:\@U;:5DLL6U_%YEC $:)0VYI%<EN% /TXHK\"]%_9P_X/-/VG_#Y^+?B/\
M:7M?AX]U$9['PM>ZUIFD7 C(RJ?9[&U=8SC VSNL@_CP<UT/_!O#_P %M_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV:[E$ZW:3$NLEO$%7:IY!//:@#]@J*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?"G[=OP:\6>#[;X?Z-J?A6>^M-4\37-O>,FGS1/<[8$@9"2$.W+C=WQ7N_\
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MM[Q5H?B?X[_&#Q1-=:]KFB7;W,%MIYD\_P J.22.,AI;AWDD4*%VQVZC_5T
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C HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>esgratingsq4v2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 esgratingsq4v2.jpg
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M4&S1(&+ =I#%X0T59CO!DM=V7OT.NL"P&^6E(V\[\UQG&AMQK@N#<7Y!X!<
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MFJ]CVKH$S%K_+YB_Y:=8NZ^<N2&.0W;F12^_=ZY8EB<FHG]35-'@#N<S#4:
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M:O4$:@]^'1]VKH+J0YJC\? VZ#:T/<;-'(;1_?JCW2?U,7W.9(Q?-AJCEXY
M[SE]T7Y:5S0:UQ8UAS7%)_WKX*UNG^.5#A7Q0IMJ>*;1JZ@QXC74&?XF]I\^
MP-/$'7K[+2VB(1J.&J><[RN</A&XIDX?3T0]X_BO7+@?[>O/P*(9N[QP@6*A
MZILCC#-_(1@2F&G@8T35C7/_5:YOHP-[SGJBA(\VV>S9=AH?O3P8Y\Y83WD8
M_*)A[M0=:/A9<*;!['?5HOVH]9[.-(0C;?$&[/_QX]B9<"=V)=R-0[?]!GO*
MU4;%'C.1\'Q[)+S:$0G/M<6OJ@S"OM.Q^W$W8M&0WKP3+O_/W=<]%I0U:2;2
M6W3V'/T<(R0\9WO+#N1NW^TY_73 !4\TW'$_TCOT"H:8;&LVXM+_^RFR1@4Z
M'<G=NLL3)^F=^P1#3#=/2?5F%K*FS?7$0.(O'K@VTV!N')E#QR'EF3>1\OS;
MR!HWQ0LNR,Q"TI^?0<IS;R/UHQI(?J(\,GH/]>I**%12JS1 \D,OX\H[E8U(
M"/RJ&YAI^$T<BH8*R)EN1,,L8S,3D+?AV1"BH:81##N!Q W I;7 Y?6F[78;
M\7#8>RSINAF'L\N-H-AO3@QO4F4'=Z+AJS>8%<O7XL6G/\>=/WS1B(37<.\O
M7\4]OW@%]QC!\)L[R^/G/WX>O7N.,YVG (L/'<:ON_1"0NV6^$[3EJ@RX6^8
MMN&?,7L#7WXNX6P#7Y;F>P_>(TX)F+[Z'W'@1"<SD$;O/91;131D9>6C_X@#
MZ-%_KW'N<['1B(9%*T]C]=KS.'SD"O8?2L'=C\S&AJTE[ULN1 ,=K<2^DW#\
M.T_B8FLS7H6 S^<?'304*[VO)XT(AGZ5E)V[L*-&'2S]^V.8>\\?,,>(C.6/
M/HT]C9HA_=AQI.X_@!6//XMECSR%I<:6//0$%O_]<:QX\CEL?+\B3HP>BQSK
MK]D?ZM$;JR7MPT]ZZ6EKGGL%>QHW1^+FK4@SY;KB1N\TB-#O-F$A$O[S;4Q=
MM!ZM^DS%U[[W#KKUFXPUZW9A]+0M.)E\!1_7ZX/;?OXVNDZ:@Z6K]F/JC!5(
MRTQ!7DXR<O-RD&L$5$[>>;/-=R%RD9QQ$,<OK,'I2WN1G9N&W/PT9&<$9C-V
M'CV)=9OVX51BP*':L'L_OO[C#]%ER#RSE84+29G8=_08+B<9@5:0BM/IV5B_
M_QC6[#^"LZF9YAZ4CI2L='-MG\.EC#0</'$1:W;O05*&N<]E96'=H2/8=_("
M<G(RO$>JCF=EHL+:,_C6A"-X??%9++^4B33SG_>HE;PP4 1*4S2P5GQGY-39
MXWB[S1MXI.%?46?P!_BB3WW4'=86[:?WQ*CEPS!G_51SGI9@R9)YF+]^CAD_
MIV+BRG$8LF@HNLWLB=83.Z'^J):H-K@A/NY= ^]TJFI$PV=XJL5;>+'-2_A3
MS?M1M7==<]Z,^"J&@')!-$3#N=/)J/K&*#2M.AE?#E^/_EV6X(/G!V'+NJ,8
MT'F)]VC1F$%K,*S7"N^%YL/[SZ%>Q?&H_\EXC!VT%L-[K\#<*=N]=R#>?+PO
M>K=;B%']5V%XGY58.F\/KJ2DX\MAZ[S\(_NM1)NZT_%YA>$X=?(R)HY8[X4/
M[[L2+6M.194W1IIQ\_I[P^$#%U"I_' C5@(BA2]7EW^H%P9V76+R+D>M#\:@
M8X-97EQQN25$@QG?+_<88\3"7=B=<*]9_@['$GZ-&=]]&'<_VQ0)KW='0KG.
M2'BM$[Y1O@OZSW?CAY:$B$5#UO1YN/3MGR/EI?>1T;ZG][B0?X8@Y<5WD7CO
M(YY=>;<*\HX<]T1$WN%CUT1#F^[!#*;,T9-PZ=]OOTY<9)JPR__U*T]0$(H4
MOI>0?^DR"JZ8@9*/)UFB(;/_"$]DI'Y0W7/^O=F.+Z>;C/E(^NOSN/3?=WGB
M(/73VE[],P>-,DY?GO=H5-(?GD#6R"^]F8RDWSWFE9T]>V&<BH;7?:+AN4)$
MPPXC%DS;&<$0,",>DHP@NG((^9>W6#,.9GEAM1%7Q7OG(]:X$0V\I7$PO':7
M6;%\/9YY_!/<\7_/&9'PFA$+% Q<EL,]OWS%A#^-%Y^JBNV;]YJ<^?C@RTE(
M:- "MS5NC81&;? O+>NCQN3[,6OCOV+ZQF]ZLP5\EZ'H H*/)W')V8JO8::Q
M*6L2L&3;'XSS8<YCE"B):-BP:2MZ]1^.M1LV!T.N9YT1X(SGTL_F;3O1?<!P
MM.S<&R/'3\'Q0MZ-(F?,M3]QVFRT[3$ 7?L-P^+EJY&6=KV .G+L!%IWZXME
MJPMOH^24''Q:>SW6;+A@TJ=B\\[+2+Z2@^V[+R,I)1O[]J<89RH56TWXDM5G
ML7M_X 7+XN)"- A)/;]$4I?PO]@=Z3_(./:!QS;]7%BV LL?? R+?_LGS#>"
MP1,$?WW$^W3K<B,V-K[_,9(V;\'B/S^(.7??YSWNM/ /#V#1G_[F"8PE)M^2
M>_^$31]^BJSS@1^*#G;JBL4F;/;=?\!<$\^T"^[[BU<FTZYZYD5DGC[MI77!
M#5^$#HJ&'I,7(^'[[V'*O)VHU7PB$G[X$88O6A=P7(US3>?[Z7>[X]_NJH5Y
MFT^9JY<.9CZRTW*-4. #35YIYA9&@92/[4<'H<>$^]!IY%-H,^INC%U4 4FI
MATW:*VC<>2Q^_U 3//]:6_SYV;I8O>LX-NX]BJ_]WWOH/709CIU/Q0./-4#Y
M]YKB<LH5K-UT#/>_U!QW_[T*?O-@9?SMY5;8L?LTCB5GXH]/-,1K53KCT9?J
MXK]^71[OUAR)Z@U&X.</?("?_*$2IL[=Z8U0^]-247/S1?QT<1(2QI[!MV>D
MH^Z>2SB>F8R,X-]Y*0JE)QHX4^.]98!Q<X:@8N>G477(!ZC:[S-4&]@(3<:V
M1]=9?3%FV6C,WS@%RP^LPH)=\[!X[4+,73,=$Y>/Q?#%P]%G_@!TG-8#S<:W
M1\WA3?%9__KXL&L-O-;I(SS6^BW\K>';N+]N!3Q<^0GL/[+CIA -?/>&[Q<,
MZKH4$X>MQ[Y=9[!IS5$D7DI#TN4T3T@,[6D<^]XK,6G41B0GIGNS!*/ZK0XX
M_"9\[I0=R#;._L;51S"PTQ(,Z;H,0[HOP^+9N[W'D"8.WW"UC'&#UV+_[K-(
MO9*)\4/77A=^<-]7?8/4E$RL7+P?J12_AJS,7*Q>>M"4O]S+-VW<)J].)>%6
MF6E('C,'>_[Y/B,8?NV)AB-&0*RZNQR>JMP7":\8P4#1\%('_->[/3%O6VF_
M@W2-B$4#%5)&]P%(_/WC2/R)<62^^RM<^OZOD=%KL!>=NWF[%T>'._%G?T+^
MJ3/(Z#L,E_[C#J1^7L]S_!-_\W?O_824%]]#BG':+__WK[T9 /M%9S[VQ/#<
M';M1D)6-Y(=>\LJ[?.?]2&O0&@49&8%W&NJV](1!LA$&*:]]%,QM3@AG'%YZ
M#P7I&4CZXU.X\N9GP1@@Y>7WD?SHJUY<]I*5R%FQSGNI.J/; %SZ[EW>2]?9
M\Y;$GVC(N6)$PQO%$ T;C*V[)APXZY!DCB=E/_(O;KPF',XN0W[2;B.BW+ST
M71JX?#Q)GED^L.\8WBQ7&W?\@(+!B(2K@D'L5?S,B(8.;8:8ILK![+V[<6?G
M3DBHUQ2W-6V.VYHU-P*B"W[<IAXZS;H+"S89P;#AZT8X&%OK%P=%M/4)1G#P
M<ZQ?Q]X3[<U@^M67TEQ07-' -FO0K!T2;OLO_/R/9BQ(NM[!3DZ^@KO^] 2^
M9N)K-6H=# WD:]*N*V[[[IU(^.?_1<+_^R$2_NE_\*\_NA==^@X)I@K M+V-
MN/^O7]Z/A'_Y 1*^^7V3UMA__!AW/_0"%IAK-Y .F+M@$1*^_FW4:=3*"_-S
M\$@J&K7?AG6;+J#?\ /HU'<W#AU+,4(B&XM7G,:!0\E&E&5A^:ISZ-QW%U:L
M/8N9"TZ8N&N/\125DHB&S"W[<+E)?UQL-O ZN]QT$,YU&H;#??OC8+>>.!#*
MNO; ,3/^7FXU%)>:#D!2AY$H2,U UH4+6/[$<YXSO^S)YW!V[GSO42+^L;BC
MPT9B[?.OXN+*U<C+RL+A?@.]QYR6//(D$C=NQI7]!Y"X92OVMNN$A7]\ $N-
M.-A:O;;W*!#+6%/N32]L5^/FN'+@(%+V[,.)L1.P\/X'L<R$[^_1.WADD5,L
MT?"]]S%]_EJLVWH8/WVH'FZ[LSR>*M\1,Y<L-TDS,'G1>GSKOM?P+W>\AV<_
MZ6J<U9W(-/WGC.FO;U=JB2=>K(_]^Y)P)?,0F@__*?K.^"LN9NS$IF,#T:#O
M?V'^IA:8L6@+_O6.]S%R\4%<0AX>_[ 3GGVW);8=.H5__.DG:-!U(1[_J#GN
M^DMU[#QT$9GY.7CTK7KXP5_>P>;]Y[!VQUE\]]Y*>.&CIMAW*1'?^WT-_.+Y
M6MARZ PJ-?T2"=]]"UT&+<;:G6=,NFIXHWI?<W39.)Z6A/;KMJ/<AG/X]MA]
M^.=1A_'-8:?PQY&[,/O 2:\-BD)IB89\2ATC9BZEI:#>X,_1:L*;J#/X?7S2
MJQ*J#6F(YA/;H^><OABU;"1F;9J(Q5L68>Z&J5BT8R+FK!^,J2M[8<3"/N@]
MLP\Z3NZ-%A.ZH/:HEOAD8'V\U[NZ$0V?XIDV[^&AIJ_C@5HOXV^?/X4^4ZX?
M0TJ#:(B&6YE(1,.&77LQ?,8\G.<'=N*<W-,7<*9B2R,8?N4]HG3HQ\\@==P\
M3-AZ%-_]L \2GFZ-;[S:"1_W7X"LX),QL2!BT<"O)A6DI7LO/%,0Y&[8XCGA
ME^_X,_).GD;*"^]ZO]AS9B'I_F>0\L:G2*U8TW/@^1*T)QKN>M!S\E,_JX/4
M2G6]]QKRSUS_%20^\L29@YQE:\SH$WA7(FOB3%S^^5^\?%=%0[U67GT2?_D
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M_N$C^ 5?@*[?W(B%-OAZDU9!:X&O-6F#A(;M\/:H1S%UW3]BUH:@\Q]2%-S
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M76Y$=L,R7:B&MO-QVW_B)7YJX\!)E#+\Z:)A*AK<6FF*!O8-Z9O^_NCO.S)
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M7N)/Z^_ =EZ[LS&,QV6W/?-*&JY+.NZ/V.U.[#BIAYP_FEQ\4E^IDVMN--/
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M)(U] ME!B'S1Q8^_?"Y9KV@Y]BH:W'(CT2"#!ON4I&/_8/CMM]]^=5M@/O_
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8+#P>/TYKB!GG'0I]     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image.jpg
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J=PU<#\/^4J5*E2I5JE2I4J7FMIS['Q-1/-?G =S"     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
